The Implication of HLA-G Molecules in Pre-eclampsia by Gede, Lene et al.

The Implication of HLA Molecules in Pre-eclampsia 
Bachelor project in Medical Biology II 
 
With Special Focus on HLA-G and HLA-C 
Roskilde University, Spring 2009 III 
Abstract 
The aim of this bachelor project is to investigate the possible immunological causes of pre-
eclampsia (PE), a syndrome which affects 5-8% of all pregnancies. Pre-eclampsia is defined as 
hypertension and proteinuria which occurs in the second half of pregnancy. It is believed that 
defective trophoblast invasion leads to incomplete remodeling of maternal spiral arteries during 
implantation, which further leads to PE. The reason for these events and the following pathology of 
the syndrome has not yet been identified.  
One of the main theories regarding the development of PE involves the immune system and the 
interaction with the Human Leukocyte Antigens (HLA). Trophoblast cells express the non-classical 
HLA molecule, HLA-G and the classical HLA-C. Furthermore, HLA-G expression is down-
regulated in pre-eclamptic pregnant women compared to healthy pregnant women. Therefore the 
focus in this bachelor project is whether these molecules could be implicated in the development of 
PE. Normally HLA-G has been reported to suppress the effect of certain immune cells, such as 
Natural Killer (NK) cells, wherefore a decreased expression could be undesirable in pregnancy. 
Different polymorphisms of HLA-G have been studied in relation to PE, and certain polymorphism 
in offspring and/or parents have been shown to be associated with an increased risk of PE. A well 
studied polymorphism is a 14 bp insertion in HLA-G that has been reported to be associated with PE 
as well as a decreased level of HLA-G expression in the placenta. Another polymorphism, G*0106, 
linked to the +14 bp allele, has also been associated with PE.  
In regard to HLA-C, one group of polymorphisms that leads to different interaction with desidual 
NK (dNK) cells has been examined, showing that this group probably is associated with an 
increased risk of PE, due to increased inhibition of dNK cells. Some hypothesize that activation of 
dNK cells is beneficial for trophoblast invasion because it results in secretion of angiogenetic 
factors, while others state that it is important to inhibit the dNK cells so that the cytotoxic effect is 
reduced. Therefore both activation and inhibition of dNK cells might play a part in PE. 
In conclusion, the cause of PE is found to be multifactorial, because none of the examined studies 
show a genetic cause or a pathway that on its own leads to PE. Instead, many mechanisms are likely 
to influence the development and several genes might influence a woman’s susceptibility to PE.  
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Abstrakt 
Formålet med nærværende bachelorprojekt er at undersøge mulige immunologiske årsager til 
udvikling af præeklampsi (PE), et syndrom som påvirker 5-8% af alle gravide. Præeklampsi 
defineres som hypertension og proteinuri opstået i sidste halvdel af graviditeten. Det menes at en 
mangelfuld trofoblastinfiltration fører til en ufuldstændig remodellering af de maternelle 
spiralarterier under graviditetsforløbet, hvormed PE opstår. Hvorfor dette sker, og årsagen til den 
efterfølgende patologi af syndromet er endnu ikke blevet klarlagt.  
En af de førende teorier for udviklingen af PE involverer immunsystemet og dets interaktion med 
Human Leukocyt Antigen (HLA). Trofoblastceller udtrykker det non-klassiske HLA-molekyle 
HLA-G, og det klassiske HLA-C. Endvidere er HLA-G-udtrykket nedreguleret i præeklamptiske 
graviditeter i forhold til normale graviditeter. Derfor vil fokus i dette bachelorprojekt være hvorvidt 
disse molekyler kan være impliceret i udviklingen af PE. Almindeligvis ses det at HLA-G hæmmer 
effekten af visse immunceller så som Natural Killer (NK) cells, hvorved et nedreguleret HLA-G-
udtryk vil være uønsket i en graviditet. Forskellige polymorfier i HLA-G er undersøgt i forbindelse 
med PE, og flere polymorfier i afkom og/eller forældre har vist sig at være associeret med en øget 
risiko for PE. En 14 bp insertion i HLA-G er grundigt undersøgt og har vist sig at være associeret 
med PE og endvidere sænke niveauet af HLA-G-udtryk i placenta. En anden polymorfi kaldet 
G*0106 som er koblet til +14 bp polymorfien, har også vist sig at være associeret med PE.  
I forbindelse med HLA-C er en gruppe polymorfier, som fører til forskellige interaktioner med 
desidual Natural Killer (dNK) celler, undersøgt og det er vist at denne gruppe sandsynligvis er 
associeret med øget risiko for PE, grundet øget inhibering af dNK celler. Nogle studier mener at 
aktivering af dNK celler er fordelagtig for trofoblastinvasionen da det resulterer i sekretion af 
angiogenetiske faktorer, mens andre mener at det er vigtigt at inhibere dNK celler således at deres 
cytotoksiske funktion reduceres. Herfor kan både aktiveringen og inhiberingen af dNK celler spille 
en rolle i PE.    
Afslutningsvis er det fundet at årsagen til PE er multifaktionel da ingen af de undersøgte studier 
hverken finder en genetisk årsag eller en signalvej, der alene forårsager PE. Tværtimod er det 
sandsynligt at mange mekanismer har en indflydelse på udviklingen og flere gener kan tænkes at 
påvirke en kvindes prædisponering for PE.      
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Preface 
This is a bachelor project, composed in the spring semester 2009 at Roskilde University. The 
project is a literary study with a biomedical approach, which seeks to clarify possible 
immunological causes of pre-eclampsia (PE). It is believed that defective trophoblast invasion and 
hereby an incomplete remodelling of maternal spiral arteries during implantation of the blastocyte 
lead to onset of PE, but the reason for these events and the following pathology of the syndrome 
have not yet been identified. One of the main theories of the etiology and pathogenesis of PE 
involves the immune system and specifically the interaction with the Human Leukocyte Antigens 
(HLA). Since trophoblast cells express the non-classical HLA molecules, such as HLA-G, and the 
classical HLA-C, the focus in this project is whether these HLA molecules could be implicated in 
the development of PE.  
It will be possible to find a list of abbreviations in the beginning of the text. Additionally, the reader 
should be aware that when referring to a gene and its encoded protein different forms are used. The 
general form is letters in italic form for genes and letters without italics for the protein. 
 
The project is directed to researchers who work with PE and immunology, and others with a 
bachelor degree in biomedicine, who are interested in the problem statement of the project.  
We would like to thank our supervisors Thomas Vauvert F. Hviid, Chief Physician at the 
Department of Clinical Biochemistry at Roskilde Sygehus and Merete Rasmussen, Assistant 
Professor at the Department of Science, Systems and Models at Roskilde University for their 
competent guidance. 
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List of abbreviations 
  
CD Cluster of Differentiation 
CD94/NKG2 C-type lectin-like molecule 
Crry Complement inhibitory receptor related protein y 
CXCR1 Chemokine Receptor 1 
DC Dendritic Cell 
dNK Decidual NK 
HLA Human Leukocyte Antigene 
IDO Indoleamine 2,3-dioxygenase 
IFN Interferon 
Ig Immunoglobin 
IL Interleukin 
ILT Immunoglobin-Like Transcript 
IP Interferon-inducible Protein 
ITAM Immunoreceptor Tyrosine-based Activation Motif 
ITIM Immunoreceptor Tyrosine-based Inhibition Motif 
KIR Killer cell Immunoglubin-like Receptor 
KIR2DL Killer cell Immunoglubin-like Receptor 2 Long cytoplasmic Domain 
KIR2DS Killer cell Immunoglubin-like Receptor 2 Short cytoplasmic Domain 
MHC Major Histocompatibility Complex 
mHLA membrane bound HLA 
NK Natural Killer 
PLGF Placental Growth Factor 
PE Pre-eclampsia 
sEng solubleEndoglin 
sFlt-1 soluble Fms-like tyrosine kinase-1 
sHLA soluble HLA  
TC Cytotoxic T cell 
TGF Tumour Growth Factor 
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TNF Tumour Necrosis Factor 
TH Helper T Cell 
TNF Tumor Necrosis Factor 
uNK Uterine NK 
URR Upstream Regulatory Region 
UTR Untranslated Region 
VEGF Vascular Endothelial Growth Factor 
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Introduction 
Pre-eclampsia (PE) is defined as hypertension that occurs in pregnancy together with proteinuria 
[Johansen et al. 2003]. PE and its related syndromes are potentially life threatening for the mother 
and the fetus, and the frequency of the syndrome is between 5% and 8% of all pregnancies 
[Preeclampsia Foundation 2008]. Recent studies suggest that the occurrence has increased with 
40% over the recent years [reviewed in Roberts et al. 2003]. On a global basis PE and eclampsia, 
which is a severe degree of PE, are said to be responsible for up to 50,000 maternal and 900,000 
perinatal deaths annually [Duley et al. 2002]. It should be noted that a difference in geographical 
occurrence of PE is observed [Larsen et al. 1993, chapter 9]. Furthermore, PE appears to have a 
heritable component as it is overrepresented in some families and seems to be passed on both 
maternally and paternally [Mogren et al.1999].  
 
There is still no treatment for PE but preterm delivery of the fetus may be essential to secure the 
lives of both the mother and the fetus. However, hypertension and the risk of seizures can be 
influenced by medication. Consequently, expensive support can be required for these premature 
infants born from pre-eclamptic births to survive. In addition, up to one-third of these infants are 
affected by intrauterine growth restriction, and are more likely to have certain health problems, both 
during pregnancy and after birth [reviewed in Chappell & Morgan 2006]. Furthermore, 
epidemiological studies have found that the effect of PE may persist long after pregnancy in the 
mother, as there is increased maternal occurrence of cardiovascular diseases later in life [Hubel et 
al. 2000; Vikse et al. 2008; Wikstrom et al. 2005].  
One of the leading theories about the cause of PE is that it results from placental interactions with 
the maternal immune system, which during pregnancy is in direct contact with the semi-allogenic 
fetus [Bainbridge et al. 2000a; Carosella et al. 1996; reviewed in Hviid et al. 2006a; Rouas-Freiss et 
al. 1997; Saito et al. 2007a]. A special type of cells, called trophoblast cells, originating from the 
fetus, invade the uterus and come into contact with the maternal immune system. Because of this, it 
is important that the maternal immune system is modulated so the fetus will not be rejected. Human 
Leukocyte Antigens (HLA), are known to be involved in graft rejection in association with 
transplantations [Ristich et al. 2005], and therefore it is hypothesized that HLA molecules could 
play a part in PE. The first HLA molecules discovered are now called the classical HLA class I 
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molecules and they were in early research studied in connection with PE, but the results were 
inconclusive and contradictory [Kilpatrick 1999]. Several investigations did not find any expression 
of classical class I or class II HLA molecules on human trophoblasts [Faulk & Temple 1976; 
Goodfellow et al. 1976]. An experiment by Redman et al. [1984] showed trophoblast expression of 
an antigen, which was detected by antibodies recognizing monomorphic class I HLA, but failed to 
bind the classical HLA-A and HLA-B polymorphic antibodies. The same results were confirmed by 
Ellis and co-workers [1986]. These results lead to the conclusion that a yet unknown HLA molecule 
existed on trophoblast cells. This molecule is today known as the non-classical HLA-class I 
molecule, HLA-G.  
From the studies mentioned above it was shown that trophoblast cells, among other antigens, 
express non-classical HLA class I. The non-classical, almost monomorphic HLA-G is until now the 
most investigated modulator of the maternal immune system during pregnancy, because of its 
presence on the trophoblast cells. An imbalance in this expression is thought to lead to 
immunological malfunctions such as PE [Bainbridge et al. 2000a; reviewed in Hviid et al. 2006a; 
Rouas-Freiss et al. 1997b]. Another HLA molecule, HLA-C, belonging to the classical subgroup is 
also expressed on trophoblast cells and has been implicated in development of PE [reviewed in 
Tabiasco et al. 2006]. 
This bachelor project will focus on the immunological implication in PE with the main focus being 
on HLA-G and to a lesser extent on HLA-C. However, other theories on the development of PE will 
briefly be described as it is the aim to give a broad overview of the subject. 
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Implantation of the Blastocyst and Development of the Placenta 
The implantation and the invasion of trophoblast cells seems to be incomplete in pre-eclamptic 
women, and the normal mechanisms of these events are described in the following to give the 
necessary background for understanding how PE develops. In early embryonic development, when 
the embryo has divided and consists of 32 cells, the cell mass is called a blastocyst. The outer layer 
of the blastocyst consists of a single layer of cells called trophoblasts. At one end of the blastocyst 
these cells are several layers thick. The inner cell mass of the thick layer is the tissue from which 
the embryo will develop, called the embryoblast (see figure 1). The trophoblasts create a coat 
around the embryoblast, which later becomes the placenta and the membranes surrounding the 
embryo; chorion and amnion, see figure 2. 
 
Figure 1: A: During implantation of the blastocyst, syncytiotrophoblasts begin to invade the uterine lining.        
B: When syncytiotrophoblasts encounter the maternal blood vessels, lacunae are formed which fills with 
maternal blood. Hereafter, cytotrophoblasts create cords which surround the syncytiotrophoblasts and lacunae, 
where embryonic blood vessels enter. This makes the exchange between the mother and the fetus possible 
[modified from Seeley et al. 2008, pp. 1086]  
About the seventh day after fertilization, the blastocyst will penetrate the uterus wall where further 
development will take place (see figure 2). During the invasion of the uterine wall, two populations 
of trophoblast cells will develop and form the embryonic portion of the placenta [Seeley et al. 2008, 
chapter 29]. One of the two trophoblast populations are called cytotrophoblasts, and this is a 
proliferating population of trophoblast cells. The other population, called the syncytiotrophoblast, is 
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nondividing and multinucleated, and these cells invade the endometrium of the uterus. They are 
nonantigenic and will therefore normally not cause an immune reaction [Seeley et al. 2008, chapter 
29]. The cytotrophoblasts on the other hand remain near the embryonic tissue. When the 
syncytiotrophoblast encounter maternal blood vessels the cells will surround them and digest the 
vessel walls. This leads to pool formation of maternal blood within lacunae (see figure 1), but 
because these lacunae during a normal pregnancy are still connected to intact maternal blood 
vessels, blood circulation is possible. The cytotrophoblasts have cords which surrounds the 
syncytiotrophoblast and lacunae. These cords have branches called chorionic with villi on them, and 
these villi protrude into the lacunae which forms the placenta. Embryonic mesoderm and blood 
vessels grow into the cords and villi as they protrude into the lacunae. When the placenta is mature, 
the cytotrophoblasts disappear, leading to separation of maternal blood supply from embryonic 
blood supply only by the embryonic capillary wall, a basement membrane and a thin layer of 
syncytiotrophoblast [Seeley et al. 2008, chapter 29]. When the fetus grows, it will need more 
nourishment and general substance exchange with the mother. This exchange takes place through 
the placenta which undergoes great changes during pregnancy. The function of the placenta is to 
exchange nutrients, metabolites and gasses between the maternal and fetal blood stream and to 
produce hormones [Seeley et al. 2008, chapter 29] 
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Figure 2: Here it is shown how PE differs from a normal pregnancy where the placental villous tree has more 
branches, and gives a proper blood supply. This restricted blood supply in PE also results from narrow spiral 
arteries, hereby making it more difficult for a proper exchange between the mother and fetus to occur.  
[Modified from Moffett & Loke 2006].  
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Pre­eclampsia  
Pre-eclampsia is defined as hypertension that occurs in pregnancy and is furthermore associated 
with proteinuria [Johansen et al. 2003], however, the diagnostic criteria of PE vary between 
countries. In Denmark hypertension in pregnancy is defined as a condition where diastolic blood 
pressure ≥ 90 mmHg or/and the systolic blood pressure ≥ 140 mmHg [Johansen et al. 2003], or if 
the diastolic pressure rises with more than 20 mmHg. If a rise in blood pressure is seen, another 
measurement needs to be taken after a few hours to confirm a permanent increase, however if the 
diastolic blood pressure is measured to 110 mmHg or more this will be enough to set a diagnose 
[Larsen et al. 1993, chapter 9]. PE is diagnosed when hypertension occurs together with proteinuria, 
which is diagnosed when measuring ≥ 0.3 g protein/24 hours [Johansen et al. 2003]. Proteinuria 
might be a sign of renal damage; since serum proteins are normally reabsorbed from urine. The 
presence of excess protein indicates either an insufficiency of reabsorption or impaired filtration. 
Furthermore oedema is often seen in connection with PE [Larsen et al. 1993, chapter 9], but is not 
necessarily a part of the diagnostic criteria. 
Severe PE is in Denmark diagnosed when the diastolic blood pressure is ≥ 110 mmHg and/or if 
subjective symptoms and abnormal findings of organ impact are seen (headache, lung oedema, 
increase in liver enzymes, etc.). The systolic blood pressure is only an indication of severe PE if it is 
> 180 mmHg [Johansen et al. 2003].  
The symptoms of PE will normally first be observed after the 20th week of pregnancy, and might be 
due to an abnormal function of trophoblast cells or a maternal immunological reaction to the 
presence of trophoblast cells. Examination of placentas from pre-eclamptic patients shows an 
insufficient trophoblast infiltration of the walls in the maternal spiral arteries. This means that the 
destruction of the contractile elements in the arteriole wall does not occur adequately, which might 
keep an increased resistance in the placental circulation, (see figure 2). Furthermore, atherosclerose-
like changes have been observed in these maternal arterioles where fibrin, trombocytes and lipid 
floating macrophages accumulate. These accumulations will partly block the arterioles, which again 
will give rise to impairments in circulation [Larsen et al. 1993, chapter 9], and the amount of 
nourishment to the fetus will decrease. 
Different aspects are thought to predispose to PE wherefore some women are more likely to 
develop the syndrome than others. Women suffering from hypertension before the onset of 
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pregnancy and women with diabetes have an increased risk [Östlund er al. 2004]. Genetic factors, 
which have been elucidated in epidemiological studies, also play a part in the development as 
described in the following paragraphs.    
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Risk Factors for the Development of Pre­eclampsia 
Several factors have been investigated in attempt to pinpoint any risk factors for PE. Especially 
numbers of prior pregnancies, familial patterns, change in partner, and interval between births have 
been given some attention in epidemiological studies. This has been done with the goal of 
illuminating any possible genetic or immunological associations in the occurrence of PE. It should 
be noted that it is difficult to draw direct parallels between different studies as they can differ in the 
definition of PE.  
Familial Patterns of Pre­eclampsia  
Pre-eclampsia appears to be more frequent in some families than others, and a woman whose 
mother has suffered from the condition is more likely to develop it herself, which shows that a 
prospective factor influencing the prevalence of this syndrome can be passed on maternally 
[Mogren et al. 1999]. Furthermore, men born of a pregnancy complicated by PE are also more 
likely to “father” a pre-eclamptic pregenancy than other men [Skjærven et al. 2005], and a woman 
who gets pregnant with a man who has had a child with another woman who developed PE also has 
an increased risk of PE [Lie et al. 1998]. The two last-mentioned findings show that paternal factors 
also contribute to PE. All this speaks for a genetic component in the occurrence of the syndrome 
that involves both maternal and paternal genes. A recent analysis using data from the Norwegian 
Birth Registry found a 1.5-fold increase in risk for PE, if the father of a pregnancy himself was born 
of a pre-eclamptic pregnancy. In comparison they found a 2.2-fold increase in risk for women born 
of a pre-eclamptic birth. The higher maternal risk association was explained by the fact that the 
mother’s genes are expressed both by the mother herself and the fetus whereas paternal genes only 
affect pregnancy through the fetus [Skjærven et al. 2005].   
The study by Lie et al. [1998] investigated familial patterns of recurrence of PE by analysing 
Norwegian birth data dating back to 1967, which included around 1.7 million births. When 
comparing the prevalence of PE for two mothers who were full sisters or half sisters, either sharing 
their father or mother, they found the following: the estimated odds ratio for association of 
developing PE was highest for full sisters (2.2), lowest for maternal half sisters (1.6) and the odds 
ratio for paternal half sisters were an intermediate (1.8). The difference between these odds ratio did 
however not reach significance. The results is not in accordance with a hypothesis presented by 
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Folgerø et al. [1996] stating that mitochondrial genes are causing PE because then paternal half 
sisters should have the lowest odds ratio because they do not share mitochondrial DNA. Lie et al. 
[1998] conclude that both the father (through genes of the fetus) and mother contribute to the risk of 
PE development.   
The Risk at the First and Following Pregnancies  
The risk of PE is known to increase with maternal age [Lie et al. 1998] but also the number of 
previous pregnancies seems to play a part. Skjærven et al. [2002] made a population based analysis 
of the births in Norway between 1967 and 1998 including more than 1.8 million births. They 
studied 551,478 women who had one or several singleton deliveries. The occurrence of PE was 
3.9% in first pregnancies and a decreasing risk of PE was found in subsequent singleton 
pregnancies. When subsequent pregnancies involved the same partner, the risk was 1.7% in second 
pregnancies and 1.8% in third pregnancies. This study failed to adjust for maternal age which might 
contribute to the slight increase in risk between the second and third pregnancy. When women with 
a history of PE were excluded from the data the risk of PE was only 1.3% in second and third 
pregnancies [Skjærven et al. 2002]. Fathers with a history of PE were not examined in this context. 
However the aforementioned study by Lie et al. [1998] found a small increase in the risk of PE if 
the father had fathered a child of a pre-eclamptic birth.  
The study Lie et al. [1998] found that the occurrence of PE appears to be greater if the mother 
changes partner between a prior pregnancy and the following compared to several pregnancies 
fathered by the same man. The risk of PE was 1.7% in second pregnancies in women which have 
the same partner as in the first pregnancy and 1.9% when the women had changed partner. This 
slight increase associated with a change of partner was significant. On the other hand a long lasting 
sex life, without use of barrier contraception, with the father before conception is associated with 
reduced risk of the syndrome [Robillard et al. 1995]. This was investigated in 1011 women - 19 of 
whom had PE, and two of whom had eclampsia. The results could be interpreted as an indicator of 
an immunological mechanism resulting in development of tolerance to the allogenic paternal sperm 
cells and thereby a future fetus. This statement is supported by the finding, that a higher risk of PE 
is associated with women conceiving by insemination with donor sperm in relation to women 
inseminated with sperm of their partners [Smith et al. 1997]. Maternal age was taken into account.    
With Special Focus on HLA-G and HLA-C 
Roskilde University, Spring 2009 11 
As mentioned before, women who experienced PE in the first pregnancy were more likely to have a 
reoccurrence in the second pregnancy. Lie et al. [1998] found that the risk was 13.1% if the second 
pregnancy was with the same partner but dropped to 11.8% if a change in partner had occurred 
(results have been adjusted for maternal age and time interval between pregnancies). This lowered 
risk could be explained if the reason for PE was due to a harmful paternal contribution and by 
changing partner this could be eliminated in the following pregnancy. The association between 
paternity and development of PE is investigated further by the aforementioned study, Skjærven et 
al. [2002], with the hypothesis that long interval between pregnancies and not a partner change is 
responsible for the increased risk of PE observed by Lie et al. [1998]. It was found that the risk of 
developing PE in a second or third pregnancy is directly related to the time since the previous 
delivery resulting in higher risk at longer intervals. That is, a pregnancy appears to protect against 
PE in a subsequent pregnancy but this protection is temporary as an interval of ten years results in a 
risk of PE equal to that of first time pregnancies even with maternal age is taking into account. 
When the analysis by Skjærven et al. [2002] was adjusted for birth interval the risk associated with 
a change of partner was actually reduced in comparison to pregnancies with no change of partner 
(in the corresponding number of pregnancy). 
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Genome Wide Scans 
Many studies have concluded that there is a familial predisposition to PE as described previously, 
and this has started the search for gene candidates responsible for PE predisposition. Research has 
been complicated by the fact that there are no natural animal models of the syndrome. The common 
belief for a long time has been that predisposition to PE was inherited maternally, and several 
models of inheritance have been proposed including paternally imprinted genes and mitochondrial 
genes [reviewed in Chappell & Morgan 2006]. Different approaches have been used to find 
candidate loci in association with PE.  
Genome wide scans have been used to zoom in on susceptible loci involved in PE [Fitzpatrick et al. 
2004; Laasanen et al. 2003; Moses et al. 2006]. This is done by comparing whole genomes, often in 
pedigrees, using genetic markers. The purpose of the scans is to find certain regions on the 
chromosomes which might be associated with PE. This search of susceptible regions in PE women 
has lead to different results, however, several studies have found chromosome 2 to be interesting in 
relation to PE [Fitzpatrick et al. 2004; Laasanen et al. 2003; Moses et al. 2006]. It would be 
interesting to make these scans in offspring of births complicated by PE and not only investigate the 
women. One problem with this screening method is that it can be difficult to obtain unambiguous 
results when analysing a big cohort where PE is seen in different families, because various loci can 
be the cause of PE in the different pedigrees [Chappell & Morgan 2006].  
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Overview  of  the  Predominant  Theories  Regarding  the  Cause  of 
Pre­eclampsia 
At the moment there are two main categories of theories regarding the cause of PE; the first 
representing the vascular theories [reviewed in Gilbert et al. 2008] and the second representing the 
immunological theories [reviewed in Redman & Sargent 2005]. They both state that incomplete 
trophoblast invasion of the uterine leads to systemic dysfunction in pregnant women, and that it 
results in hypertension and proteinuria, however, it is controversial what causes this dysfunction.  
The focus of the vascular theories is, among other things, the link between placental ischaemia and 
maternal endothelial dysfunction and oxidative stress which seems to be an important component of 
the pathophysiology in both the placental and maternal circulation [reviewed in Gilbert et al. 2008; 
Redman & Sargent 2000]. Furthermore, circulating debris from the placenta, which is thought to 
contribute to the systemic disturbances in PE, has been given a great deal of attention [Redman & 
Sargent 2000]. Pre-eclampsia is by some thought to be associated with an enhanced inflammatory 
response originating from the innate immune system [Germain et al. 2007] and it has been 
suggested by Redman & Sargent [2000] that circulating debris from the placenta, causes the 
systemic disturbances in PE.  
Regarding the immunological theories, evidence points to a maternal immune response caused by 
interaction with HLA molecules from the fetus [Knight et al. 1998; Rouas-Freiss et al. 1997b]. The 
theories in question also address the dysfunctions in maternal development of tolerance towards the 
fetus. Since the immunological factor in the development of PE will be the focus of present 
bachelor project, the vascular theories will not further be discussed.    
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Introduction to the Human Immune System 
The immune system is overall divided into the innate and the specific acquired immune system. The 
innate immune system consists of external barriers; skin, mucus etc, and in addition to this it 
consists of cells such as phagocytic cells and Natural Killer (NK) cells that can react against 
different kinds of pathogens (see paragraph “The Function of NK Cells in Relation to HLA 
Molecules”) [Seeley et al. 2008, 792, 797]. Common for the factors in the innate immune system is 
that they do not react against a specific pathogen but use a more general mechanism in the first 
attempt to handle an infection. The cells of the innate immune system are always available and 
ready to respond. Nevertheless, the innate immune system is not as effective as the specific 
acquired immune system, at least not in a longer time perspective. Since present project focus on 
different HLA molecules in relation to PE the specific acquired immune system is more relevant, 
because this specifically recognizes different kinds of HLA molecules. Later in this project a more 
detailed description of NK cells is given and described in association with HLA molecules (see 
paragraph “The Function of NK Cells in Relation to HLA Molecules”). 
The Specific Acquired Immune System 
The specific acquired immune system react on foreign antigens from viruses, bacteria etc. that are 
presented via HLA molecules on the cell surfaces. The subgroup HLA class I molecules are found 
on nucleated cells throughout the body, whereas HLA class II molecules belong to antigen-
presenting cells like B cells and macrophages [Seeley et al. 2008, pp. 801]. There are roughly two 
types of mechanisms for the acquired immune system: the antibody-mediated immunity and the 
cell-mediated immunity [Seeley et al. 2008, pp. 799]. The two types of mechanisms will be 
elucidated in the following, where a typical way of action by the specific acquired immune system 
will be described (see figure 3).  
The first step in an immune response is when a macrophage phagocytizes and processes a foreign 
antigen and combines it with a HLA class II molecule. This leads to the presentation of HLA class 
II/antigen complexes on the surface of the macrophage. The macrophage must then enter the lymph 
system to reach a helper T cell (TH) which has a receptor for the specific antigen. TH cells are some 
of the main lymphocytes in the immune system, and they have a central role in activating and 
regulating an immune response. When a TH cell binds to an antigen presented by a macrophage, the 
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macrophage secretes cytokines to activate the TH cell. The TH cell can stabilize the binding to the 
macrophage by a glycoprotein called CD4 which binds to HLA class II molecules. After activation 
the TH cell divides [Seeley et al. 2008, pp. 802-804], and the resulting TH cells can activate B cells 
that have phagocytized the same specific type of antigen as the TH cell has recognized. The B cell 
presents the antigen via HLA class II molecules in the same way as the macrophage. Hereafter, TH 
cells can bind to the HLA class II/antigen complex and activate the B cell though the binding, but 
activation also takes place, because TH cells co-stimulate the B cell with CD4-binding and by 
secretion of interleukins. The activated B cell divides manifold and become plasma cells producing 
antibodies against a specific antigen [Seeley et al. 2008, pp. 805]. The antibodies are released into 
the body fluids and are effective against extracellular antigens for instance from bacteria [Seeley et 
al. 2008, pp. 808]. The antibodies bind to specific antigens and can activate the complement system 
which causes the cell to lyse because of digestion of the cell membrane. Furthermore the 
complement system attracts macrophages and other cells of the innate immune system. Antibodies 
also make it easier for the macrophages to phagocytize the antigen, because the antibodies bound to 
an antigen binds directly to macrophages [Seeley et al. 2008, pp. 809-810].  
Not all of the B cells differentiate to plasma cells and secrete antibodies; some of the B cells 
become memory B cells that stay in the body. The memory B cells assure that, if the body is 
infected once again with the same antigen, the B cells are able to divide quickly to plasma cells and 
produce a rapid response by producing large amounts of antibodies within hours or a few days. In a 
first time response it usually takes 3-14 days to produce the necessary amount of antibodies to fight 
an infection [Seeley et al. 2008, pp. 811]. 
In addition to activating B cells and the antibody-mediated immunity, TH can also activate cytotoxic 
T cells (TC) and initiate the cell-mediated immunity. This immune response is effective against 
intracellular microorganisms – for instance if a cell has been infected with a virus. Cytotoxic T cells 
recognize antigens that are presented by HLA class I molecules on the target cell. They bind to the 
cell surface receptor with CD8 and not CD4 as opposed to TH cells. Binding to the target cell 
stimulates TC cells, but before they can act, they need to be co-stimulated for instance by released 
interleukins from TH cells. An activated TC cell divides to create more TC cells as well as memory T 
cells that function like the memory B cells in a secondary infection. The function of TC cells is 
based on the binding to target cells presenting the foreign antigen. This binding causes the TC cell to 
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release substances that results in lysis of the target cell. The TC cell also releases cytokines that 
stimulate macrophages and cause an inflammatory response [Seeley et al. 2008, pp. 812-813]. 
 
Figure 3: The figure provides an overview of the immune system.  An antigen is phagocytized by a macrophage 
which then activates a helper T cell. Hereafter the immune response is subdivided into the antibody-mediated 
immunity and the cell-mediated immunity. The first step in the antibody-mediated immunity is when the helper 
T cell activates a B cell, whereby the B cell is stimulated to divide into antibody producing plasma cells and B 
memory cells. The antibodies react against cells, presenting the specific antigen. In the cell-mediated immunity, 
the helper T cell activates a cytotoxic T cell that divides, and also forms memory T cells.  An active cytotoxic T 
cell cause lysis of target cells expressing the foreign antigen and they secrete cytokines attracting other cells of 
the immune system [modified from Seeley et al. 2008, pp. 815]. 
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As described above the function and regulation of the immune system is highly based on different 
cytokines such as interleukins released from different cells at different points during an immune 
response. In the next paragraph a more detailed description of different cytokines released from T 
cells will be presented.  
TH1/TH2 Response and Cytokine Profiles  
Helper T cells can be divided into two main groups: TH1 cells and TH2 cells that differ in cytokine 
profiles. Whether naive TH cells differentiate to TH1 or TH2 cells is determined by the environment 
and the first stimulation from the innate immune system [Murphy et al. 2008, pp. 352]. The 
knowledge about the different types of responses is relevant in the discussion of causes of PE 
because in some studies it has been observed that PE is associated with a change from a TH2 
response in normal pregnancies to an overall TH1 response [reviewed in Sargent et al. 2006]. 
The differentiation of TH cells to TH1 cells is triggered by the cytokines Interferon gamma (IFN-γ) 
and interleukin (IL)-12. When TH1 cells recognize a specific antigen on a target cell it releases IFN-
γ leading to stimulation of more T cells to differentiate into TH1 cells [Murphy et al. 2008, pp. 352-
353]. TH1 cells stimulate antibody production by stimulating B cells to produce antibodies against 
foreign, extracellular microorganisms [Murphy et al. 2008, pp. 350]. The TH1 cell response is also 
believed to be the major factor in autoimmune diseases like type I diabetes [Murphy et al. 2008, pp. 
607-608].  
TH2 cells are formed if the naive TH  cells are stimulated by IL-4 [Murphy et al. 2008, pp. 352] and 
like the mechanism of TH1 cell differentiation, TH2 cells secrete IL-4 themselves and hereby 
stimulate the differentiation of more naive TH cells into TH2 cells [Murphy et al. 2008, pp. 353]. 
The TH2 cells mainly function by enhancing the B cell production of the immunoglobulin E class of 
antibodies that fight parasite infections. The response of TH2 cells is the main response in for 
instance allergic reactions [Murphy et al. 2008, pp. 350]. The TH1 and TH2 response is mutually 
inhibitory [Raghupathy 1997].  Even though TH cells can be divided into TH1 and TH2 cells it is not 
possible to distinguish completely between a TH1 and a TH2 response. The overall immune response 
is based on a balance between the two types; some immune responses might consist of more TH1 
cells than TH2 cells, but the main point is that there still are some TH2 cells acting in the defence 
mechanism and therefore a clear division cannot be made for the two types of responses.  
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In addition to TH cells, several other types of T cells have been found. Regulatory T cells that do not 
stimulate the immune response but rather inhibit it have been discovered. The regulatory T cells are 
subdivided into two groups: regulatory T cells that differentiate in the thymus – called natural 
regulatory T cells and the regulatory T cells differentiated from naive T cells in the periphery – 
called the adaptive regulatory T cells [Murphy et al. 2008, pp. 351, 355]. Natural regulatory T cells 
probably function directly through the contact with its target cell, but it might also secrete IL-10 and 
Transforming growth factor (TGF)-β that inhibit the proliferation of T cells. IL-10 reduces the 
release of IL-2, IFN-α and IL-5 by T cells and thereby suppresses the T cell response, and at the 
same time it reduces the expression of HLA and co-stimulation by antigen presenting cells. IL-10 
inhibits for example Dendritic Cell (DC) secretion of IL-12 and thus inhibits the differentiation into 
TH1 cells [Murphy et al. 2008, pp. 355].  
Among the group of adaptive regulatory T cells are the TH3 cells, which are found in the mucosal 
immune system, and they secrete IL-4, IL-10 and TGF-β. They, among other things, inhibit immune 
responses against foreign antigens in food in the intestines. Interestingly, some experiments have 
shown that it is possible to develop tolerance against self-antigens when given orally – probably due 
to the function of TH3 [Murphy et al. 2008, pp. 355]. Perhaps this could also be relevant in the case 
of PE. If one of the factors involved in the syndrome is paternal antigens, it might be possible to 
induce tolerance against these via orally induced tolerance (see paragraph “Tolerance Induction and 
Pre-eclampsia”). 
Furthermore, CD4+ CD25+ regulatory T cells and the transcription factor forkhead box P3 
(FOXP3), which is the marker for regulatory T cells in humans, may also be important during 
pregnancy. Steinborn et al. [2008] found a decrease in the number of CD4+ CD25+ FOXP3+ 
regulatory T cells during normal pregnancy and an even lower number in women affected by PE. 
Furthermore, the functional activity of these cells was significantly reduced when compared to 
those of healthy pregnants. A study by Arruvito et al. [2007] refer to a previous study who showed 
that CD4+ CD25+ regulatory T cells completely suppress TH1 proliferation [Arruvito et al. 2007], 
which are wishful in obtaining a successful pregnancy, which will be further described in paragraph 
“TH1 and TH2 Response and Pre-eclampsia in Relation to HLA-G”. To get an overview of the 
different T cells and their function, see table 1. 
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Table 1: The cytokine profiles and function of different types of T cells are summarized [modified from Bendtzen 
et al. 2001, pp. 91; Murphy et al. 2008, pp. 350-353]. 
 
 
 
T cell Stimulated by 
the following 
cytokine(s) 
Secretes 
the 
following 
cytokine(s) 
Overall function of the cells 
TH1 IFN-γ,   
IL-12 
IFN-γ,  
IL-2 
Stimulates cell-mediated immune response – 
activates macrophages, and is an important factor 
in autoimmune diseases and transplantations. 
TH2 IL-4 IL-4,  
IL-5, 
IL-10   
Stimulates antibody production – especially IgE. 
Important in the antibody-mediated immune 
response. 
Natural 
regulatory T 
cells 
TGF-β IL-10, 
TGF-β 
Suppresses T cells in the immune system 
CD4+ CD25+ 
FOXP3+ 
regulatory T 
cells 
-  - Modulate the immune response; suppress TH1 
proliferation 
TH3 IL-10 IL-10,  
TGF-β 
Inhibits immunity against foods in the intestines 
With Special Focus on HLA-G and HLA-C 
Roskilde University, Spring 2009 23 
Tolerance 
It is possible to induce tolerance against a specific foreign antigen, but the main aspect of tolerance 
is to make sure that T cells and B cells with receptors for self-antigens are destroyed or at least 
suppressed in some way. Furthermore, immunological tolerance is important in the general 
regulation of an immune response, and seek to that the immune system does not lead to unnecessary 
harm of the body [Seeley et al. 2008, pp. 805-808]. Some evidence have suggested that a woman is 
able to develop tolerance against the foreign antigens of her partner, thereby avoiding an immune 
response against a future fetus and maybe get protection against PE. As mentioned it has been 
observed that the risk of developing PE is reduced if the woman has had a long sexual relationship 
with the father, without use of barrier contraception, before the pregnancy [Robillard et al. 1995]. 
Still, the way tolerance is induced is not well understood.  
A way to prevent activation of lymphocytes and induce tolerance is to alter the antigen receptor or 
inhibit the co-stimulation which is necessary for normal function of the lymphocytes [Seeley et al. 
2008, pp. 808]. The dose of antigen is also important if tolerance has to be induced. Very low or 
very high doses are more likely to be related with tolerance than doses in between, which instead 
will lead to immunity a [Bendtzen et al. 2001, pp. 125-126]. Furthermore, the passageway of the 
antigen has an effect because cutaneous or intramuscular administration normally causes immunity 
whereas oral intake or intravenous injections stimulate tolerance. The orally induced tolerance 
could be mediated via TH3 cells as described in the previous paragraph. Tolerance is often not 
complete – sometimes only the cell-mediated immunity is tolerant but the antibody-mediated 
immunity is not and vice versa [Bendtzen et al. 2001, pp. 125-126]. 
Many different theories have been proposed to explain how a semi-allogenic fetus is tolerated 
during pregnancy by the maternal immune system – in spite of paternally derived antigens. A 
number of these theories will be described in the following paragraph. 
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Reproductive Immunology – The Fetus is a Tolerated Allograft 
A fetus can be considered as a semi-allograft because the genome of the fetus is half maternal and 
half paternal so the fetus will express paternal HLA during the pregnancy that differs from the 
mothers. Successful pregnancies in humans depend, among other things, on a balance between 
maternal acceptances of the fetus without hindrance of immune responses towards potentially 
harmful infections in the organisms. The complex mechanisms of feto-maternal tolerance and 
acceptance have puzzled many immunologists and yet no comprehensive explanation has emerged. 
Billingham and Medawar did in 1953 propose an explanation for the immunological interaction 
between the mother and her fetus. They proposed four hypotheses: 1) the conceptus lacked 
immunogenicity, 2) a significant lowering of immune responses during pregnancy, 3) the uterus is 
an immunoprivileged site, 4) there is an elaboration of an immune barrier by the placenta [reviewed 
in Thellin et al. 2000].  
In the following years after Billingham and Medawar published their article, three of their four 
hypotheses were rejected. The last mentioned hypothesis concerning the elaboration of an immune 
barrier is still being investigated but now it is believed that this barrier is a site, which actively 
tolerates the semi-allogenic fetus, whereas earlier the site was believed to be passive or neutral. The 
immuno-tolerance state is thought to work though several active mechanisms [Guleria & Sayegh 
2007; Sacks et al. 1999; Thellin et al 2000]. 
In the following paragraph, hypotheses explaining these active mechanisms by which the fetus is 
protected from the maternal immune system will be described. Apart from the potential role of 
HLA-G which is widely discussed [Bainbridge et al. 2000a; reviewed in Hviid et al. 2006b; Rouas-
Freiss et al. 1997b], there are studies concerning several other cells and molecules in relation to this 
HLA-G [Thellin et al 2000].  
 
The Expression of Non-Classical HLA Molecules by Trophoblast Cells  
The maternal-fetal interface consists of, among other things, the interstitial trophoblast cells which 
are in contact with the maternal decidua and expresses the non-classical HLA-G, HLA-E, HLA-F 
and classical HLA-C (see paragraph “Human Leukocyte Antigen”). Since HLA-G, HLA-E, and 
HLA-F is only slightly polymorphic in comparison to the classical HLA class I molecules, they are 
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properly not recognized as foreign by the mother’s immune system and can thereby avoid detection 
and destruction. Hereby the fetus might be protected against NK cells [Guleria & Sayegh 2007; 
Hunt et al. 2005].  Furthermore, HLA-G’s primary function is thought to be impairment of the 
cytotoxic and lytic functions of both NK- and T cells [Carosella et al. 1999; Hunt et al. 2005] (see 
paragraph “HLA-G and its Interaction with Immune Cells”). This does not completely explain the 
survival of the fetus, but it might play a part in this.  
Other mechanisms than immunological tolerance might also protects the fetus, because studies of 
both Shomer et al. [1998] and Rogers et al. [1998] have investigated, by transgenic technology, 
whether trophoblast cells would be rejected if they did not express HLA class I molecules. In both 
studies the trophoblast cells did survive. Since the main focus in this project is the function of HLA 
class I molecules this will be described in greater detail throughout the rest of the project and not in 
this paragraph. Instead present paragraph will outline other theories regarding maternal tolerance of 
the fetus.  
 
Tryptophan Catabolism by the Enzyme Indoleamine 2.3-dioxygenase (IDO)  
The enzyme, indoleamine 2.3-dioxygenase (IDO), catabolises tryptophan, which is an essential 
amino acid necessary for T cell proliferation and thereby T cell activation. IDO is produced by cells 
near the maternal-fetal interface and it is expressed in a high level on extravillious trophoblasts in 
humans. One of the proposed hypotheses, which include IDO as a factor in immunological 
tolerance, states that IDO catalyses tryptophan near the placental area and thereby the maternal 
immune reactions are inhibited in the area near the fetus [reviewed in Thellin et al. 2000]. 
Interestingly, the maternal serum level of tryptophan is reduced during pregnancy [Munn et al 
1999]. This hypothesis was tested by exposing pregnant mice to a pharmacological agent that 
inhibits IDO enzyme activity. The mice were either carrying syngeneic or allogeneic fetuses. The 
results showed that in pregnant mice exposed to 1-methyl-trypthophan no allogenic conceptus 
remained more than 9.5 days after fertilization. For syngeneic fetuses the trend was different, and 
the mice remained pregnant. This experiment is consistent with the hypothesis of IDO-producing 
cells regulating the maternal immune reaction [reviewed in Munn et al. 1999].     
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TH1/ TH2 Balance in Immuno-tolerance 
Studies have shown that during pregnancy the TH1/TH2 balance in the placenta is shifted towards 
the TH2 response. The balance can be a critical factor for tolerance of the semi-allogenic fetus 
[Sacks et al. 1999; reviewed in Thellin et al. 2000; Wegmann et al. 1993]. It is known that there are 
beneficial and deleterious cytokines in relation to pregnancy, where TH1 cytokines are related to 
generation of inflammatory responses, whereas TH2 cytokines generates non-inflammatory 
responses. The deleterious cytokines like IL-2, IFN-γ, and tumour necrosis factor (TNF) increases 
NK cell activity and induces the cell mediated immunity [reviewed in Wegmann et al. 1993]. These 
cytokines are synthesised by TH1 cells and are generally harmful for the maintenance for 
pregnancy. The hypothesis concerning a TH2 favoured balance, explains a successful pregnancy 
because the TH2 cells secrete cytokines that down-regulate the TH1 cytokines [Raghupathy 1997] 
(see paragraph “TH1 and TH2 Response and Pre-eclampsia in Relation to HLA-G”).   
Role of Complement Activation in Pregnancy 
Complement regulatory proteins such as decay-accelerating factor and membrane cofactor protein, 
which are expressed on human trophoblasts, prevents the complement activation damage. This is 
important in maintaining a successful pregnancy [Guleria & Sayegh 2007]. This was tested in mice 
in which the complement inhibitory receptor related protein y (Crry) is a functional homolog of the 
above-mentioned complement regulatory proteins which negatively regulates the components of the 
complement cascades; complement component 3 and complement component 4. Studies have 
shown that this negative regulation is important for the sustainment of embryos because Crry-
deficient mice embryos die [reviewed in Erlebacher 2001]. Furthermore it is important to notice, 
that results show that Crry-deficient embryos are not damaged when the mother is genetically 
complement component 3-deficient. These results indicate that in pregnancy, inhibition of the 
complement system by complement regulatory proteins in order to prevent activation of the 
complement pathway is necessary [Erlebacher 2001; Guleria & Sayegh 2007]. 
 
Placental Hormones Acting on the Immune System 
Progesterone is clearly an essential hormone during pregnancy. It acts on trophoblastic tissues and 
on the immune system leading to lowering of the immune responses [Thelin & Heinen 2003]. 
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Piccinni et al. [1995] have investigated the effect of progesterone on the cytokine production. The 
result showed that T cells in the presence of progesterone exhibited a significantly increased 
production of IL-5 and IL-4 compared to T cell lines in the absence of progesterone. The result of 
Piccinni and colleagues [1995] indicates that progesterone induces the development of naive TH 
cells into TH2 cells [Piccinni et al. 1995].  
It is likely that not one but multiple mechanisms are included and contribute to the presence of 
maternal tolerance of the fetus and a successful pregnancy. The reproductive immunology is still an 
open field and many questions are still to be answered. In the next paragraph the HLA molecules 
will be described in detail before looking more into the possible functions of HLA molecules in 
pregnancy. 
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Human Leukocyte Antigens 
Histocompatibility antigens are genes encoding proteins which are implicated in tissue graft 
compatibility. They are divided into two systems, those of the Minor Histocompatibility antigens, 
which cause a graft tissue to be slowly rejected, and those of the Major Histocompatibility Complex 
(MHC), which cause a fast and strong rejection [Bendtzen et al. 2001, pp 69]. The MHC is a large 
genomic region located on the short arm of chromosome 6 in humans. This region contains more 
than 200 densely packed genes with the majority of these related to immunological functions. As 
mentioned these MHC-genes are also known as HLA’s in humans [Glodsby et al. 2003, pp. 161]. 
The proteins encoded by these HLA genes are expressed on the surface of cells and display both self 
antigens and non-self antigens to T cells that have the ability to kill or coordinate the killing of 
pathogens or malfunctioning cells. The MHC is divided into regions encoding three different classes 
of HLA molecules: HLA-I, -II and –III, with the HLA-I region located in the telomeric end of the 
chromosome, the HLA-II region in the centromeric end, and the HLA-III region in the middle (see 
figure 4) [Glodsby et al. 2003, pp 162]. These three different classes of molecules differ structurally 
and therefore perform slightly different functions.  
 
• Class I HLA genes: These genes encode glycoproteins, which major function is to present 
self antigens and foreign antigens to TC cells. 
• Class II HLA genes: These genes resemble very much HLA-I genes, but have the ability to 
present processed non-self antigenic peptides to TH cells.  
• Class III HLA genes: These genes encode a variety of proteins that do not present peptides 
like class I and II HLA molecules, but some nevertheless modulate or regulate immune 
responses. 
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Figure 4: Shows a gene map of the human leukocyte antigen (HLA) region. The HLA region is located on the 
short arm of chromosome 6, with the class II molecules positioned closest to the centromer, the class I molecules 
positioned closest to the telomeric end, and the class III molecules in between [modified from Mehra & Kaur 
2003, pp. 4]. 
The HLA­I Molecules 
The HLA-I molecules are subdivided into class Ia and Ib, also referred to as the classical and non-
classical HLA genes, respectively. The classical HLA molecules are encoded by three loci; HLA-A, 
HLA-B, and HLA-C. They are located on the cell surface of almost all nucleated cells, and are 
known to be very polymorphic [Glodsby et al. 2003, pp. 162; HLA Informatics Group, 2009a]. The 
non-classical HLA molecules are also encoded by three loci; HLA-G, HLA-E and HLA-F. In 
contrast to the classical HLA molecules, the non-classical HLA molecules show only slight 
polymorphism, and their expression is limited to certain cell types [Glodsby et al. 2003, pp. 162; 
HLA Informatics Group, 2009a]. They also differ in function from the classical molecules, which 
will be presented in the following paragraphs. The non-classical HLA molecules were not 
discovered and characterized until the mid 1980’es. The first of the non-classical molecules to be 
discovered was HLA-G, which was detected in an experiment made by Redman et al. [1984]. Both 
classical and non-classical HLA proteins consist of a heavy chain, called the α-chain, encoded in the 
MHC region by HLA genes, and a smaller non-covalently associated β-chain (β2-microglobulin), 
which is encoded by a highly conserved gene on chromosome 15. Because of this it is the α-chain 
and not the β-chain that determines whether the molecule for instance is a HLA-A, -B or -C 
molecule [Bendtzen et al. 2001, pp 71; Janewy et al. 2005, pp 122] (see figure 4). The hydrophobic 
part of the α-chain spans the cell membrane, with the majority of the chain exposed on the external 
site of the cell and a smaller part of the chain at the cytoplasmic site. The external part of the α-
chain consists of three domains; α1, α2 and α3 which are held together in the right functional 
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conformation by the β2-microglobulin domain. The α1- and α2- domains interact to form a peptide 
binding cleft that displays small peptides with a size of 8-10 amino acids. The α3-domain, which is 
similar in size and organization as β2-microglobulin, is located near the cell membrane and 
contributes to the binding of CD8 [Glodsby et al. 2003, pp. 166-167] (see figure 5). Variations seen 
in the classical HLA molecules are most frequently due to differences in the amino acid sequence 
encoding the α1- and α2-domains, which constitute the peptide binding cleft [Bendtzen et al. 2001, 
pp. 71; Glodsby   et al. 2003, pp. 174].    
 
Figur 5: The general structure of HLA class I and class II molecules. The HLA class I and class II molecules both 
have four external domains; α1, α2, α3, β in regard to class I molecules and α1, α2, β 1, β2 in regard to class II 
molecules, where the α1 & α2, and the α1 & β 1 makes up the peptide binding cleft for the class I and -II 
molecules, respectively. Furthermore both molecules consist of a transmembrane α-helix and a cytoplasmic tail, 
with class II molecules having two transmembrane α-helixes and cytoplasmic tails [modified from Goldsby et al. 
2003, pp. 166]. 
 
The HLA­II Molecules  
The HLA-II molecules encoded by three loci; HLA-DR, HLA-DP and HLA-DQ are primarily 
located on antigen presenting cells, like B cells, DCs, monocytes and macrophages [Glodsby et al. 
2003, pp. 162]. These molecules are structurally very similar to the HLA-I molecules, but differ in 
some areas. The HLA-II molecules, like HLA-I molecules, consist of an α-chain and a β-chain 
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constituting a non-covalent, heterodimeric complex, but in the HLA-II molecules both the α-chain 
and the β-chain are encoded by genes in the MHC region so that both the α- and β-chain determine 
if the molecule for instance is a HLA-DR, -DP or -DQ molecule. Each chain consists of a 
transmembrane segment, a cytoplasmic tail, and four external domains, an α1- and α2-domain that 
is part of the α-chain, and the β1- and β2-domain which is part of the β-chain. In the HLA II 
molecules the binding cleft is made up of the α1- and β1-domain, in contrast to HLA I molecules, 
where it is the α1- and α2-domain that constitute the binding cleft [Glodsby et al. 2003, pp. 168] 
(see figure 5). It is not clear which part of the HLA-II molecule that contributes to the binding of 
CD4, but it has been suggested that two regions in the β1- and β2-domain may bind CD4 [Nag et al. 
1993]. Crystal structure of HLA-II molecules shows that they fold up very much like HLA-I 
molecules, but with the major difference located at the ends of the peptide binding cleft which are 
wider in HLA-II molecules. This means that larger peptides, around 13-18 amino acids, can be 
bound by HLA-II molecules, and will protrude out, while peptides that bind to a HLA-I molecule 
are substantially buried within the molecule [Glodsby et al. 2003, pp. 168; Janeway et al. 2005, pp. 
126]. To get an overview of the different classes of HLA molecules see table 2. 
Tabel 2. An overview of the classical HLA class I molecules, non-classical HLA class I molecules and HLA class 
II molecules in regard to loci, binding domain, bound peptides and location. 
 
HLA classes Loci in 
humans 
Binding 
domain 
Length of 
bound peptides 
Location 
HLA – Ia 
(Classical) 
HLA-A 
HLA-B 
HLA-C 
α1 / α2 8-10 amino 
acids 
Displayed on almost all nucleated 
cells and on trombocytes. 
HLA – Ib 
(Non-
classical) 
HLA-G 
HLA-E 
HLA-F 
α1 / α2 8-10 amino 
acids 
Displayed on certain specific cell 
types.  
HLA – II HLA-DR 
HLA-DP 
HLA-DQ 
α1 / β1 13-18 amino 
acids 
Primarily located on Antigen 
Presenting Cells (APC) like: B-
cells, monocytes, dendritic cells 
and macrophages. 
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Allelic Variations of the HLA Genes  
Apart from the non-classical HLA-I genes, the HLA genes are some of the most polymorphic genes 
known in higher vertebrates, which give rise to major allelic variation. In humans, several hundred 
different allelic variations have been identified for some HLA class I and HLA class II loci (See 
Table 3) [HLA Informatics Group, 2009a]. As mentioned before, variations in HLA class I 
molecules is primarily due to differences in the amino acid sequence in the α1- and α2-domain, 
which makes up the peptide binding cleft. HLA class II molecule polymorphism is mostly due to 
variations in the α1- and β1-domain, which are the domains that constitute the peptide binding cleft 
in these molecules. Because these polymorphisms are found mainly in the peptide binding cleft, 
they lead to different binding affinity for a variety of different peptides. This gives the molecules 
the ability to display a great variety of peptides, which permits the immune system to respond 
specifically to an enormous array of antigeneric peptides [Bendtzen et al. 2001, pp. 71, Glodsby et 
al. 2003, pp. 171].  
In class I molecules only the α-chain is encoded by the MHC region and shows polymorphism. In 
class II molecules both the α- and β-chain is located on chromosome 6 and both show 
polymorphism in the HLA-DP and HLA-DQ molecules. In HLA-DR the α-chain does not show 
polymorphism. Instead five different β loci are located in the MHC region, which all encode 
molecules that show polymorphism. The appearance of different β loci in an individual can vary 
from one to four. Because HLA genes are co-dominantly expressed, this can lead to formation of 
hybrids. Thus for example an allelic variant of the β-chain from the paternal chromosome can 
combine with an allelic variant of the α-chain form the maternal chromosome and form a hybrid. 
This makes the number of different HLA molecules expressed in the population even greater. 
[Bendtzen et al. 2001, pp. 73]. 
As mentioned above the non-classical HLA molecules show very little polymorphism compared to 
the classical HLA molecules. There are found 42 alleles of HLA-G at the nucleotide level, which 
have been acknowledged by the WHO Nomenclature Committee for factors of the HLA System. 
An even more restricted variation is seen when looking at the protein level, where only 14 proteins 
have been observed in regard to HLA-G. In addition two null alleles have been found. Similarly, 9 
and 21 alleles have been detected for HLA-E and HLA- F respectively at the nucleotide level and 
only three and four alleles, respectively, have been observed at the protein level [HLA Informatics 
Group, 2009a] (See Table 3).  
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Tabel 3 Data of the total number of alleles and protein concurrency of the classical and 
non-classical HLA genes [modified from the HLA Informatics Group, 2009a]  
 
 
 
 
 
 
Because the MHC is polygenic and the allelic variation is high for most of the HLA molecules, it 
reduces the chance of finding an individual with a haplotype that matches that of another individual. 
In people who have received a transplant, a difference in haplotype can lead to rapid rejection of the 
transplant because of an immune response to the allogeneric HLA molecules [Bendtzen et al. 2001, 
pp. 76, 79].  
It have been speculated that a similar response is the reason for development of PE, where 
especially the non-classical HLA molecule, HLA-G, are thought to play a part because of its special 
expression pattern [reviewed in Redman & Sargent 2005; Rouas-Freiss et al. 1997b]. Therefore it is 
relevant to look into HLA-G allelic variations and isoforms. 
Allelic Variation and Isoforms of HLA­G  
Allelic Variation 
As mentioned earlier there are acknowledged 42 alleles of HLA-G at the nucleotide level, where 
two of these are null alleles and the rest results in 14 protein variations. The polymorphisms 
resulting in the 14 protein variations are scattered on the three α domains [Clements et al.2005]. 
The G*0106 allele, which is associated with PE [Moreau et al. 2008], has a polymorphism located 
in the α3-domain [Clements et al.2005; HLA Informatics Group 2009a]. This is interesting because 
a binding site for the Immunoglobin-like transcript 2 (ILT2) receptor (located on some immune 
cells) in the HLA-G molecule is located in the α3-domain. However, the polymorphism of the 
G*0106 allele do not alter the binding sequence of ILT2 directly. Nevertheless, it could be 
speculated that this and other polymorphism located in the α3-domain could change the 
conformation of the domain and thereby disrupt the ILT2 binding site. Furthermore, as mentioned 
Gene HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G 
Alleles 733 1,115 392 9 21 42 
Proteins 573 942 307 3 4 14 
Nulls 48 39 9 0 0 2 
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before, there are also two null alleles which results in early truncation: the G*0105N allele and the 
G*0113N allele. In the G*0105N allele a deletion mutation in codon 130 in exon 3 causes a 
frameshift and premature stop at codon 171. In the G*0113N allele a point mutation at codon 54 in 
exon 2 causes a premature stop codon [HLA Informatics Group, 2009b]. 
The polymorphisms acknowledged by the WHO Nomenclature Committee for factors of the HLA 
System, are located in the coding region, but polymorphisms are also detected in non-coding 
regions of the gene, inter alia the 5’-Upstream Regulatory Region (5’URR) and 3’-Untranslated 
Region (3’UTR) part of HLA-G [Hilby et al. 1999; Hviid et al. 1999; Ober et al. 2003]. This is 
interesting because different polymorphisms in these regions may influence the regulation of the 
HLA-G expression [Hviid et al. 2004; Ober et al. 2003]. Most studies have focused on looking at 
polymorphisms located in the coding regions, however one extensively studied polymorphism is a 
14 bp deletion (5’-ATTTGTTCATGCCT-3’) located in the 3’UTR region at position 3741 in exon 
8. Hviid et al. [2003] showed that different alleles are associated with different expression patterns, 
but in general alleles containing this +14 bp insertion polymorphism showed a significantly lower 
HLA-G mRNA expression level than the alleles where the 14 bp were deleted. This polymorphism 
will be further discussed in relation to PE in paragraph “HLA-G Polymorphisms and Assosiation 
with Pre-eclampsia” together with the other polymorphisms in the coding regions.  
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HLA­G Isoforms 
In contrast to other class I molecules HLA-G is expressed in several different isoforms caused by 
alternative splicing of HLA-G mRNA. There have been identified seven splice variants. Four of 
these, HLA-G1 to -G4, are membrane bound [Ishitani & Geraghty 1992; Kirszenbaum et al. 1994], 
while the remaining three, HLA-G5 to -G7, are soluble [Fujii et al. 1994; Paul et al. 2000]. The 
membrane bound HLA-G1, which is nearly identical in structure to the other class I genes, include 
the transmembrane segment, the cytoplasmic tail and the three external domains α1, α2 and α3. The 
HLA-G2 isoform is missing exon 3, which encodes the α2-domain, and may form homodimers that 
more closely resemble HLA class II molecules structurally. In HLA-G3, both exon 3 and 4, 
encoding domain α2 and α3, are spliced out [Ishitani & Geraghty 1992], and in HLA-G4 the α3-
domain is absent caused by exclusion of exon 4 [Kirszenbaum et al. 1994] (See figure 6). However, 
it is uncertain whether these two isoforms, HLA-G3 and -G4, can be expressed on the cell surface 
[Bainbridge et al. 2000b]. 
The soluble HLA-G (sHLA-G) isoforms are generated from mRNAs that retain intron 2 in regard to 
HLA-G7 and intron 4 in regard to HLA-G5 and –G6. Both of these introns contain a stop codon 
thus precluding the translation of the transmembrane region, making the molecules soluble [Fujii et 
al. 1994; Paul et al. 2000]. HLA-G5 and –G6 structurally resemble the HLA-G1 and –G2 
respectively, but in a soluble form, while HLA-G7 only consists of the α1-domain, caused by the 
early truncation generated by the stop codon in the retained intron 2 (See figure 6). Besides 
production of soluble forms of HLA-G through alternative splicing, soluble HLA-G can also be 
generated at the post-translational level by metalloproteinase-dependent shedding. This is in most 
studies denoted sHLA-G1, why this term will be used throughout this bachelor project [Park et al. 
2004].  
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Figure 6: Splicing of the different isoforms [modified from Hviid et al. 2006a]. 
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Expression Pattern of HLA Molecules in the Placenta 
As mentioned earlier the expression of non-classical HLA class I molecules is limited to certain 
specific cell types, but commonly they are all expressed on the placental trophoblast cells [Ishitani 
et al. 2003], with HLA-G having the strongest expression. In addition to the strong expression of 
HLA-G observed on the trophoblast cells of the placenta, HLA-G protein expression has also been 
detected in the thymus and some immune cells are shown to secrete a soluble form of HLA-G in 
peripheral blood [Crisa et al. 1997; Lila et al. 2001; Rebmann et al. 2003].  
The expression of HLA-F has been detected primarily on extravillous trophoblasts that invade the 
maternal decidua [Ishitani et al. 2003], while HLA-E, like the classical HLA molecules, is 
expressed in a great range of tissues [Lee et al. 1998a]. 
Neither the class II HLA molecules nor the classical HLA class I molecules are found to be 
expressed in the placenta, with the exception of a weak expression of the classical HLA-C molecule 
[King et al. 2000a; Redman et al. 1984]. This makes the function of non-classical HLA molecules 
and the classical HLA-C molecule interesting in regard to the mother’s acceptance of the semi-
allogenic fetus during pregnancy. Therefore, a further look into the non-classical HLA molecules 
and HLA-C would be relevant in connection to PE. HLA-G is to date the most extensively studied, 
but interesting studies have also been made regarding HLA-C and PE. Little is known about HLA-E 
and HLA-F, wherefore the main focus will be on HLA-G and HLA-C. Furthermore there will be a 
short presentation of HLA-DR, even though it normally cannot be detected in the placentas from 
healthy pregnant women. However, it is interesting to look into because HLA-DR expression has 
been observed in placentas from PE women [reviewed in de Luca Brunori et al. 2000] (see 
paragraph “The association between HLA-DR and Pre-eclampsia”).    
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The Function of NK Cells in Relation to HLA Molecules  
Several new hypotheses regarding the development of PE include some kind of interaction between 
HLA molecules and NK cells, and thus it is relevant to describe these immune cells in detail. The 
function of NK cells will therefore be related to the HLA class I molecules. 
NK cells are large granular lymphocytes and are categorized as part of the innate immune system 
[Coico & Sunshine 2009, pp. 15]. Of the circulating lymphocytes, NK cells account for about 10-
15% [reviewed in Tabiasco et al. 2006], and NK cell activity has been observed in the mucous 
membranes of the intestines and the respiratory passages [Bendtzen et al. 2001, pp. 130]. In the 
decidua basalis of a pregnant woman, the NK cells accounts for about 70% of the lymphocytes 
[reviewed in Tabiasco et al. 2006], and this is one of the facts that makes the NK cells very 
interesting in relation to pregnancy and PE.  
In contrasts to T and B cells the NK cells do not have antigen-specific receptors. Instead NK cells 
scan other cells to find out whether these cells carry a HLA class I molecule on their surface. The 
HLA class I molecule binds to an inhibitory receptor on the surface on the NK cell. Through this 
mechanism the HLA class I molecule inhibits the activity of the NK cell so it cannot release its 
intracellular granules that would eventually cause the cell to lyse or lead to apoptosis [Coico & 
Sunshine 2009, pp. 15]. In the absence of a HLA class I molecule the NK cell will be activated (see 
figure 7). This mechanism of the NK cell is effective since many virus infected cells or transformed 
(tumor) cells lack the HLA class I molecules or have a decreased expression of these, making them 
easier to recognize by the NK cell [Coico & Sunshine 2009, pp. 15]. Virally infected cells also often 
secrete IFN-α and IFN-β that work as activators of NK cells [Coico & Sunshine 2009, pp. 315]. The 
function of NK cells is an important support to the work of T cells since these cells only recognize 
cells which display foreign antigens and do not respond in the case of cells lacking HLA molecules, 
in which case the NK cell is activated [reviewed in Yokoyama & Riley 2008]. 
NK cells also have activating receptors that recognize special molecules on the cell surface and 
stimulate the NK cells, however the ligands for those receptors are not well defined [Murphy et al. 
2008, pp. 99]. One single NK cell has many activating and inhibitory receptors and the decision of 
the action of the NK cell is made on the basis of the balance between the activating and inhibitory 
signals from the receptors [Roitt & Delves 2001, pp. 70].  
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Killer Function of NK cells 
When the NK cell attaches to a target cell and is activated, the granules in the NK cell release their 
contents into the space between the NK cell and the target cell resulting in lysis or apoptosis of the 
target cell [Roitt & Delves, 2001, pp. 18-19].  
In addition NK cells have FcγRIII (CD16) receptors that recognize cells coated with antibodies. 
This means that NK cells kill target cells that have been marked with antibodies by the specific 
immune system. This function of the NK cells is called the antibody-dependent cellular cytotoxity 
[Roitt & Delves 2001, pp. 70] (see figure 7c). 
 
Figure 7: NK receptors and their function. a) Shows the inhibitory receptor that suppresses the activity of NK 
cells because of binding to a HLA class I molecule. b) Shows that the NK cells are activated, when the inhibitory 
receptor fails to detect a HLA class I molecule, so only the activating receptor bound to its ligand produces a 
signal to the NK cell. c) Shows the FcγRIII receptor that recognizes antibodies on the cell surface and activates 
the cytotoxic activity of the NK cell [modified from Roitt & Delves, 2001, pp. 70]. 
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When the NK cell is activated it does not only lead to lysis of the target cell but it also releases 
cytokines that attract other relevant parts of the immune system. NK cells can for instance produce 
IFN-γ, which activates macrophages that release IL-12, which triggers NK cells to enhance the 
secretion of IFN-γ [Wood 2001, pp. 32].  
As described, the HLA class I molecules interact with the NK cells trough special receptors, and 
thus the HLA class I receptors on NK cells will be the focus in the next paragraph. 
NK Cell Receptors that Recognise HLA Class I Molecules 
Three different types of NK cell receptors that bind HLA class I molecules exist: Killer cell 
immunoglobulin-like receptors (KIR), C-type lectin-like molecules (CD94/NKG2) and ILT. All the 
three different groups of receptors have both activating and inhibitory subtypes [reviewed in 
Borrego et al. 2001; reviewed in King et al. 2000b]. 
The inhibitory receptors of the three different receptor groups all have immunoreceptor tyrosin-
based inhibition motifs (ITIM) in their cytoplasmic domain [reviewed in Borrego et al. 2001]. The 
ITIM is phosphorylated when the HLA molecule binds the receptor and via a signal pathway this 
leads to dephosphorylation of a number of proteins that is necessary in an activation signal. When 
the proteins are dephosphorylated the NK cell activity is inhibited [reviewed in Borrego et al. 2001; 
reviewed in Yokoyama & Riley 2008].  
The activating receptors lack the ITIM, but typically have a charged residue in the transmembrane 
sequence which associates with an immunoreceptor tyrosin-based activation motif (ITAM) that has 
an adaptor protein – for instance DAP12  [reviewed in King et al. 2000b]. The activation of an 
activating receptor and the following ligation of the ITAM with the adaptor molecule initiate a 
mechanism that leads to phosphorylation of essential proteins in the activation pathway leading to 
activation of NK cell lytic function [reviwed in Borrego et al. 2001].  
In the following the three different receptor types will be examined. 
Killer Cell Immunoglobulin­like Receptors (KIR) 
Killer cell immunoglobulin-like receptors are found almost exclusively on NK cells [reviewed in 
King et al. 2000b], and they have either two or three Ig-like domains and are named according to 
this by designating them KIR2D and KIR3D, respectively. Isoforms of KIR with long cytoplasmic 
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domains have the ITIM and are inhibitory as described above. Two of the inhibitory isoforms are 
called KIR2DL and KIR3DL– ‘L’ stands for long cytoplasmic domain. KIR2DS and KIR3DS are 
activating and involve DAP12 in the activation mechanism [Roitt & Delves, 2001, pp. 70] – ‘S’ 
stands for short cytoplasmic domain (see figure 8). 
 
Figure 8: Structures of inhibitory and activating KIR, shown with both two and three Ig-like domains (γ1-3). 
From left to right the KIR on the figure are designated: KIR2DL, KIR3DL, KIR2DS, and KIR3DS [modified 
from King et al., 2000b, pp. S82]. 
 
Different KIR isoforms recognize different HLA class I molecules. KIR2D binds HLA-C whereas 
subsets of HLA-A and HLA-B are the ligands of KIR3D receptors [reviewed in Borrego et al. 
2001]. KIR2D distinguishes between two groups of HLA-C allotypes – the difference between the 
allotypes is a dimorphism located in the α1-domain [reviewed in King et al. 2000b]. The inhibitory 
KIR2DL1 recognizes HLA-C belonging to the HLA-C2 group (HLA-Cw2, -Cw4, -Cw5, and -Cw6) 
and KIR2DL2 are specific for the HLA-C1 group (HLA-Cw1, -Cw3, -Cw7, and -Cw8) [reviewed 
in Yokoyama & Riley 2008]. 
The activating KIR2DS does, however, not have a high affinity for HLA-C, and therefore HLA-C is 
thought to mainly associate with the inhibitory KIR2DL and inhibit the NK cell activity [reviewed 
in Borrego et al. 2001]. KIR2DL4 is a special isoform because it has both a long cytoplasmic tail 
with an ITIM and a charged residue in the transmembrane sequence. Perhaps this could indicate that 
KIR2DL4 is both inhibitory and activating [reviewed in Borrego et al. 2001; reviewed in King et al. 
2000b]. Some studies show that HLA-G binds to this KIR receptor, while others show that HLA-G 
only binds to ILT, a receptor type which will be described later in this paragraph [reviewed in 
Borrego et al. 2001]. 
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C­type Lectin­like Molecules (CD94/NKG2)  
C-type lectin receptors are heterodimers of CD94 that is covalently bound to a molecule of the 
NKG2 family [reviewed in Borrego et al. 2001]. These receptors are specific for the non-classic, 
non-polymorphic HLA-E molecule and have both activating and inhibitory isoforms (see figure 9) 
[reviewed in Borrego et al. 2001; reviewed in King et al. 2000b].  
 
Figure 9: Structures of inhibitory (CD94/NKG2A) and activating (CD94/NKG2C) C-type lectin molecules 
[modified from King et al. 2000b, pp. S82] 
 
HLA-E presents antigens derived from peptide sequences from other HLA class I molecules, and it 
has been confirmed that HLA-G and HLA-C leader peptides are capable of binding to HLA-E 
[reviewed in King et al. 2000b]. If no HLA class I molecules are produced in the cell, HLA-E 
cannot be expressed on the cell surface and hereby it cannot interact with NK cells [Roitt & Delves 
2001, pp. 70]. An example of CD94/NKG2 is CD94/NKG2A, whereas CD94/NKG2C is considered 
to be activating [Roitt & Delves 2001, pp. 70; reviewed in Yokoyama & Riley 2008]. The affinity 
of CD94/NKG2C binding to HLA-E is lower than binding of HLA-E with the inhibitory receptor 
CD94/NKG2A [reviewed in Yokoyama & Riley 2008]. The affinity for HLA-E is also influenced 
by the specific HLA class I molecule peptide sequence bound by HLA-E (see paragraph “The 
Involvement of HLA-E and HLA-F in Pre-eclampsia”). 
Immunoglobulin­like Transcripts (ILT) 
Immunoglobulin-like transcripts are expressed on monocytes, macrophages, dendritic cells (DCs), 
B cells, NK cells, and T cells [reviewed in Borrego et al. 2001]. Some of the ILT subtypes 
recognize different kinds of HLA class I molecules [reviewed in Borrego et al. 2001]. The 
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inhibitory receptors ILT2 and ILT4 have been shown to bind HLA class I molecules [reviewed in 
Yokoyama & Riley 2008]. ILT2 is the only one presented on NK cells, and has been shown to bind 
HLA-G [Colonna et al. 1997]. ILT2 interaction with HLA class I molecules inhibits NK cell 
activity as well as B cell and monocytic activity [reviewed in Borrego et al. 2001]. 
From the previous it is can be deduced that NK cells directly recognize cells with HLA class I 
molecules via KIR and ILT and indirectly via CD94/NKG2 because of the binding to HLA-E. 
Decidual NK Cells and Interaction with HLA Class I Molecules 
NK cells all express the marker CD56, but the expression level varies in different NK cells. The NK 
cells that have a high expression level of CD56 are named CD56bright, whereas the others are 
designated CD56dim cells; last-mentioned accounts for the greatest part of peripheral NK cells. 
CD56dim cells are associated with high cytotoxic activity whereas the CD56bright cells instead secrete 
cytokines to a higher extend [reviewed in Yokoyama & Riley 2008]. NK cells in uterine mucosa 
differ from the ones found in the rest of the body as these NK cells are mainly CD56bright and they 
are CD16- negative (CD16-) [Yokoyama & Riley 2008, pp. 175]. The antibody dependent cell 
cytotoxicity of NK cells works via CD16 as described previously, and therefore the NK cells in the 
uterine mucosa do not have this function. Furthermore, NK cells in the uterine mucosa have low 
cytotoxicity levels, but are capable of secreting different cytokines, chemokines and growth factors 
[reviewed in Yokoyama & Riley 2008] (see paragraph “HLA-C and Pre-eclampsia”).  
Some researchers distinguish between decidual NK (dNK) cells and uterine NK (uNK) cells, and 
define uNK cells as the ones found in the uterus endometrium, which are also present in non-
pregnant women, and dNK cells are the NK cells at the implantation site in pregnant women – in 
the deciduas basalis [reviewed in Tabiasco et al. 2006]. However other researchers seem to use the 
two terms synonymously. We will use the term dNK cells, as this definition is restricted to NK cells 
in deciduas in pregnant women, because we focus on the mechanisms in pregnancy.  
Much research indicates that dNK cells must have specialized functions, for instance the gene 
expression pattern are quite different from that of peripheral NK cells [reviewed in Tabiasco et al. 
2006]. Some research on dNK cells focus on the interaction with HLA molecules, because dNK 
cells are in contact with the extravillous trophoblast cells that express HLA-C, HLA-G, HLA-E and 
HLA-F [Shobu et al. 2006]. In the following we will describe some studies of the special 
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interaction between dNK receptors and HLA class I molecules, but in general the expression of 
different receptors on dNK cells varies among individuals [Verma et al. 1997]. 
Expression of CD94/NKG2 by dNK Cells 
Koopman et al. [2003] showed that the activating CD94 associated receptor, NKG2C, is expressed 
at a much higher level in dNK cells (three- to fivefold increase) compared to peripheral NK cells. 
Unfortunately the expression level of the inhibitory receptor CD94/NKG2A was not examined, 
although the expression of NKG2A by dNK cells was observed. 
However, King et al. [2000b] write that they have observed that dNK cells express the inhibitory 
CD94/NKG2A at a five times greater intensity than peripheral NK cells [unpublished results, 
reviewed in King et al. 2000b]. Furthermore, they showed that 95% of dNK cells will bind to 
soluble HLA-E tetrameric complexes, and this binding is inhibited, when using monoclonal 
antibodies against CD94 [King et al. 2000c], which indicates that HLA-E binds to CD94/NKG2 on 
dNK cells. 
Decidual NK Cell Expression of KIR Receptors with Affinity for HLA­C 
Specific KIR receptors for HLA-C are found to be expressed on dNK cells. Furthermore, it has been 
reported that KIR2D which binds to HLA-C is present in a larger scale in dNK cells than NK cells 
in the peripheral blood [Verma et al. 1997]. However, the expression of inhibitory receptors in 
relation to activating receptors has not been investigated. Nevertheless, these results could support 
the hypothesis that HLA-C plays a part in regulating the NK cell activity during pregnancy. 
Expression of ILT2 and KIR2DL4 by dNK Cells in Relation to HLA­G 
The importance of HLA-G can be through binding of its leader sequence to HLA-E which binds to 
NK cells via CD94/NKG2. It is also possible that HLA-G interacts with NK cells trough binding to 
ILT2, because this receptor binds HLA class I molecules – including HLA-G [Colonna et al. 1997]. 
About 25% of the dNK cells are believed to express ILT2 [King et al. 2000c]. LeMaoult et al. 
[2005] have shown that HLA-G up-regulate the expression of ILT-2 and also KIR2DL4 in 
peripheral NK cells, indicating that HLA-G might play a part via those receptors, although it might 
act different on dNK cells (see also paragraph “HLA-G and its Interaction with Immune Cells”).  
It has recently been shown that HLA-G1 and HLA-G5 can also be found as disulphide-bonded 
homodimers when they are expressed on trophoblast cells. The disulfide bond connects the α-
domains of two HLA-G1 or HLA-G5 molecules. These homodimers have an orientation that makes 
The Implication of HLA Molecules in Pre-eclampsia 
Bachelor project in Medical Biology 46 
the ILT2 and ILT4 binding site of HLA-G dimers more accessible, hereby making it possible to 
bind to two ILT receptors. This is not the case for HLA-G monomers which can only bind to one 
ILT receptor and furthermore have a lower affinity and a higher dissociation rate for the receptor, 
compared to HLA-G dimers. Overall, this and the fact that ILT2 mostly was found to bind cell 
surface dimers both in vivo and in vitro, means that HLA-G dimers have a higher potential for 
inhibiting immune cells than that of HLA-G monomers. Because of these findings it will be 
relevant for analysis strategies to distinguish between monomers and dimers, which have not yet 
been done [reviewed in Carosella et al. 2008]. Therefore, it is possible that research showing only a 
weak binding effect of HLA-G on ILT2 does not correspond to reality if only monomers of HLA-G 
have been studied. 
Furthermore KIR2DL4 has an increased expression in the dNK cells indicating that this receptor 
plays a part in the function of dNK cells [Koopman et al. 2003]. It is proposed that KIR2DL4 binds 
HLA-G and through this mechanism HLA-G might have a significant role in pregnancy [reviewed 
in King et al. 2000b]. Binding of KIR2DL4 is by some believed to inhibit NK cell activity even 
though the structure of the receptor is a bit different compared to other inhibitory KIR receptors 
[reviewed in Yokoyama & Riley 2008]. However recent research has shown that KIR2DL4 is 
predominantly found in endosomes in NK cells, and that it mediates endocytosis of its ligand, 
which is soluble HLA-G. The endocytosis leads to activation of the NK cell to secrete 
proangiogenic factors [Rajagopalan et al. 2006]. This might indicate a role of HLA-G in the 
activation of NK cells to secrete cytokines and not just inhibition of NK lysis. Figure 10 
summarizes the association between trophoblast derived HLA class I molecules and receptors on 
dNK cells. 
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Figure 10: The figure shows the dNK cells receptors for the HLA class I molecules presented on trophoblast 
cells. HLA-E bound to a HLA class I leader peptide binds the CD94/NKG2 receptor on dNK cells. HLA-G is 
shown to bind both KIR2DL4 and ILT2 on the dNK cell. And HLA-C bind KIR2D receptors on dNK cells 
[designed by the authors].  
 
The Role of HLA Molecules in the Inhibition of dNK Cells’ Lytic Funtion 
It is believed that the predominant function of HLA class I molecules on trophoblast cells is to 
inhibit the dNK cell mediated lysis of target cells. This theory was supported by King et al. [2000c] 
because they showed that the dNK cell mediated lysis of .221 cells expressing HLA-E was inhibited 
when transfecting the cells with HLA-C and HLA-G. When adding anti-CD94, the lysis ability of 
dNK cells was partially restored, indicating that HLA-C and HLA-G inhibit lysis via HLA-E. When 
monoclonal antibodies against HLA class I molecules were added the cells were not resistant to 
lysis, showing that HLA class I molecules are the factor protecting against NK cell killing. 
Furthermore dNK cells were not able to lyse isolated trophoblast cells, and maybe this is because 
they normally express HLA class I molecules. However, when King et al. [2000c] used antibodies 
against all the HLA class I molecules or all the receptors, thought to be involved in the interaction 
with dNK cells (ILT2, KIR, CD94/NKGD2), the dNK cells were still not able to induce lysis in the 
trophoblast cells. This indicates that the HLA class I molecules might not be the important factor in 
prevention of lysis of dNK cells as suggested until now, and perhaps the HLA class I molecules 
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interact with NK cells in other important pathways instead (see paragraph “HLA-C and Pre-
eclampsia”).  
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HLA­G Polymorphisms and Association with Pre­eclampsia  
Because of the immunological maladaptation theory, candidate genes for PE might be found among 
genes with immunological functions in the placenta. Focus has been on HLA-G because of the 
presence of HLA-G molecules on extravillous trophoblast cells which are the only fetally derived 
cells in contact with the maternal immune system. HLA-G expression is believed to be important 
for acceptance of the semi-allogenic fetus as HLA-G expression has been shown to, among other 
things, protect against NK mediated cell lysis (see paragraph “HLA-G and its Interaction with 
Immune Cells”). Several studies have reported a reduced or aberrant HLA-G expression in pre-
eclamptic placentas and serum [Emmer et al. 2004; Hunt et al. 2000; O’Brien et al. 2001; Yie et al. 
2004] compared to successful pregnancies, which will be described below.  
The Level of Soluble and Membrane Bound HLA­G in Serum and Placenta in 
Pre­eclampsia 
It has been shown in a study by Hunt et al. [2000] that sHLA-G in serum is significantly higher in 
pregnant women compared to non-pregnant women and therefore sHLA-G can be important in 
pregnancy. Yie et al. [2004] investigated the amount of sHLA-G in blood serum and placentas from 
20 women with PE and 14 controls. They found decreased amounts of sHLA-G in serum of pre-
eclamptic women and in their placentas. Emmer et al. [2004] have found a tendency towards more 
HLA-G5 in 12 placentas from pre-eclamptic women compared to 15 normotensive women. This 
result contradicts the common results obtained on this matter. O’Brien et al. [2001] analysed 
placentas from 11 normal pregnancies and 7 placentas from women with mild PE, and overall he 
found a low HLA-G transcription level. Five out of six PE placentas (the level was not determined 
for one of the PE placentas) especially showed a clear reduction of the HLA-G3 isoform and this 
reduction was not seen in placentas from normal pregnancies. Furthermore, four of the five 
placentas showing reduction of HLA-G3 were homozygous for the +14 bp polymorphism which 
will be described later in this paragraph. Some studies have, however, shown that the HLA-G3 
isoform does not reach the cell surface, which means that it is unlikely to play a part in the 
immunoregulation of pregnancy [Bainbridge et al. 2000b], however, this is contradicted by Riteau 
et al. [2001], who showed that HLA-G3 can inhibit the function of some immune cells (see 
paragraph “HLA-G and its Interaction with Immune Cells”). 
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Several other studies have found abnormally low expression of HLA-G mRNA and protein in 
placentas of pre-eclamptic women [reviewed in Hviid 2006a] but this could be a result, rather than a 
cause, of the syndrome. Nagamatsu et al. [2004] investigated this aspect by analyzing the effect of 
deficient oxygen supply on primary extravillous cytotrophoblasts in regard to expression of mHLA-
G and sHLA-G. They found that short-term hypoxia does not lower the amount of either mHLA-G 
or sHLA-G. Importantly this supports that the subnormal amount of HLA-G molecules found in 
pre-eclamptic women is not likely to be caused by placental hypoxia. However, Nagamatsu et al. 
[2004] did not examine the long-term result of hypoxia. Furthermore, Goldman-Wohl et al. [2000] 
showed that a down-regulation of HLA-G in pre-eclamptic placentas were not due to necrosis of 
placental tissue, but probably due to a lower level of HLA-G expressed by the trophoblast cells. The 
above gives the impression that HLA-G expression normally is found to be reduced in PE cases.   
HLA­G Allele Distribution in Pre­eclamptic Cases and Normal Pregnancies  
When examining different studies that investigate an association between PE and different 
polymorphisms, it is important to establish whether it is the genotype of the offspring or of the 
mother, which is analysed. Furthermore it is important to note whether the study is done on 
primiparas, multiparas, or both because PE is more frequent in primiparas than multiparas. When 
following paragraph does not specify whether primiparas or multiparas are used in the study, it is 
because the article has not made any distinction on this. In such cases it is believed that both groups 
have been included.  
Methods of obtaining DNA from the mother and fetus should also be taken into account. Maternal 
serum can be contaminated with fetal DNA and conversely placental biopsies can be contaminated 
with maternal tissue and therefore these methods of obtaining DNA are questionable. There is a 
small risk of maternal contamination of blood from the umbilical cord and fetal contamination of 
maternal whole blood samples, however, the chance of this is so small that this is considered a 
validated method. In the following paragraphs studies investigating different polymorphisms in 
connection with PE will be described. 
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The G*0105 Null Allele is not Associated with Pre-eclampsia  
The G*0105N allele possesses a single bp deletion in exon 3 in codon 130, which gives a premature 
stop codon in exon 4 (see paragraph “Human Leukocyte antigen”). The stop codon results in 
blocked transcription of some HLA-G isoforms: G1, G4 and G5. However the isoforms in which 
exon 3, containing the deletion, has been spliced out: G2, G3, G6 and G7 are translated correctly 
[Le Discorde et al. 2005]. 
The frame shift mutation in the G*0105N allele makes it interesting to investigate in relation to PE. 
This was done by Aldrich et al. [2000] who analysed the genotype of 57 infants from PE births, and 
111 controls from uncomplicated pregnancies via placental tissue. No significant difference in the 
allele distribution between any of the groups was seen in regards to the G*0105N allele. This was 
supported by Hylenius et al. [2004] who investigated the allele in 57 severe PE triads and in 98 
controls. The triads included both parents and their infant and subjects were subdivided into 
primiparas and multiparas. Blood samples were taken in pregnancy for genotyping of the mother 
and at birth from umbilical cord for genotyping of the infant. Hylenius et al. [2004] observed the 
G*0105N allele in a very low frequency in control triads but not in PE cases. Aldrich et al. [2000] 
found one case where a fetus was homozygote for the G*0105N allele in which case the mother did 
not have PE. The above implies that the null allele does not contribute to PE.  However this does 
not rule out that HLA-G plays a part in the development of PE because some isoforms, as 
mentioned, are transcribed and might compensate for the missing isoforms in the G*0105N allele 
[Le Discorde et al. 2005].  
 
Maternal Inheritance of G*0104 and its Significance in Pre-eclampsia 
In a study by Carreiras et al. [2002] mother-child genotypes were investigated for 27 pre-eclamptic 
and 29 normotensive healthy pregnant Venezuelan women and their infants. Carreiras et al. [2002] 
observed that six pre-eclamptic infants had the G*0104 allele and five out of the six inherited the 
allele from their mother. This pattern was different for the controls where the allele was seen in 
seven infants and only one mother had the allele, which means that six out of the seven inherited the 
allele from their father. Therefore Carreiras et al. [2002] suggest that inheritance of maternal 
G*0104 should be considered as a conditioning factor for the development of PE. The conclusion 
The Implication of HLA Molecules in Pre-eclampsia 
Bachelor project in Medical Biology 52 
was, however, not supported by results of Hylenius et al. [2004] who investigated the parental 
transmission of the G*0104 allele and found no association. 
 
The +14 bp Polymorphism and its Significance in Pre-eclampsia 
The presence of a specific HLA-G polymorphism (+14) in the fetus has been reported to increase 
the risk of PE [Hylenius et al. 2004; Moreau et al. 2008; O’Brien et al. 2001]. This polymorphism 
is located in exon 8 (3’UTR) and is a 14 bp long insertion. Allele frequencies for Caucasians are 
58% for -14 bp and 42% for +14 bp [reviewed in Castro et al. 2000]. The extra sequence seems to 
be an evolutional remnant as it is restricted to humans and do not exist in baboons and other 
primates. This means that the polymorphism actually results of a deletion rather than an insertion 
[Castro et al. 2000].  
The aforementioned study by Hylenius et al. [2004] found an overrepresentation of the +14/+14 bp 
HLA-G genotype among the offspring of pre-eclamptic women. A total of 22.8% of the children 
from the PE triad carried the +14 bp/+14 bp genotype in contrast to 11.2% of control children. 
These data included both primiparas and multiparas and the result were only borderline significant. 
When only the primiparas were analysed, the occurrence of the +14 bp/+14 bp genotype in the 
offspring of pre-eclamptic women was 30% compared to 7.1% in control offspring and the results 
reached statistical significance. It appeared that the combination of mother-child genotype could 
influence the occurrence of PE as several +14 HLA-G alleles in the mother and fetus together were 
associated with PE in primiparas. The +14 allele was absent in only 12.5% of PE mother/child pairs 
in contrast to 28.6% of control pairs. In addition, a trend in transmission of the +14 bp sequence 
was observed; the +14 bp polymorphism was often paternally inherited in children of pre-eclamptic 
women whereas the -14 bp polymorphism was more often paternally inherited in control cases. The 
maternal transmission of the allele was random [Hylenius et al. 2004].  
In addition, Hylenius et al. [2004] investigated HLA-G incompatibility between the pregnant 
women and the fetuses by testing the number of children that carried a polymorphism inherited 
from the father and which the mother did not carry. There was no significant evidence of HLA-G 
incompatibility in general.    
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In conclusion, both paternal transmission of the +14 bp sequence and the +14 bp/+14 bp genotype 
of the offspring appear to confer a risk of PE. The risk via paternal transmission is not because of a 
general HLA-G incompatibly between the fetus and the mother because this was investigated by 
Hylenius et al. [2004] and because several +14 bp alleles in the mother and fetus together showed 
to infer increased risk of PE. The correlation between PE and the +14 bp polymorphism in 
offspring has also been reported by O’Brien et al. [2001] and Moreau et al. [2008]. The later 
especially found an association when the +14 bp sequence was coupled with the G*0106 
polymorphism which will be mentioned later in this paragraph. However, other studies have not 
found an association between +14 bp polymorphism in offspring and PE; Iversen et al. [2008] 
studied the genotype of mothers and fetuses using blood samples from the mother and from the 
umbilical cord. In total 31 women with PE were included and further subdivided into mild (26) and 
severe (5) PE. As controls 29 healthy pregnant women and 14 non-pregnant women were analysed. 
Pre-eclampsia was neither associated with a maternal or fetal HLA-G +14 bp allele. Fetal HLA-G 
+14 bp genotype was reflected in the profile of decidual HLA-G mRNA splice forms, but did not 
seem to increase the risk of PE [Iversen et al. 2008]. However the method used to obtain maternal 
DNA by Iversen et al. [2008] are problematic because they purified DNA from blood serum and 
this can as mentioned be contaminated with fetal DNA. The study by Bermingham et al. [2000] has 
also not been able to find any significant correlation between PE and the +14 bp sequence neither in 
parents or offspring. Vianna et al. [2007] investigated the distribution of the +14 bp genotype of 
162 healthy pregnant women and 157 pregnant women with PE using whole blood samples. No 
significant differences were found in the alleles of controls and PE women. In fact the primiparas 
PE women exhibited a higher frequency of the -14/-14 bp genotype (12%) compared with the 
primiparous control women (9%). Vianna et al. [2007] did not investigate if an association was 
present between the + 14 bp polymorphism and PE fetuses such as it was found by Hylenius et al. 
[2004], Moreau et al. [2008], and O’Brien et al. [2001].  
 
The Relation Between the +14 bp Insertion and the Level of HLA-G Expression 
One could speculate that the +14/+14 bp genotype could result in PE through an immunological 
response because of a reduced expression of HLA-G in the placenta. Hviid et al. [2004] and Chen et 
al. [2008] have both investigated whether the +14 bp polymorphism is linked to differences in 
sHLA-G expression in serum. This was investigated in non-pregnant women and men in both 
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studies. Hviid et al. [2004] generally observed that sHLA-G in serum was low, however, sHLA-G 
was undetectable when the samples were homozygous for the 14 bp insertion. Furthermore, Chen et 
al. [2008] observed a significantly lower sHLA-G level in serum when the genotype was +14 
bp/+14 bp compared to both, +14 bp/-14 bp and -14 bp/-14 bp. The differences in sHLA-G serum 
levels were, however, not significant for the genotype +14 bp/-14 bp and -14 bp/-14 bp. Both 
studies suggest that the 14 bp deletion/insertion polymorphisms play a part in expression of sHLA-
G.  
Studies indicate that the +14 polymorphism leads to two mRNA products; the normal transcript and 
an alternative splicing which results in the splicing out of 92 bp of exon 8 [Fujii et al. 1994; Hiby et 
al. 1999; O’Brien et al. 2001]. To investigate if alternative splicing of the polymorphic allele 
influences the stability of the mRNA transcript, Hviid et al. [2003] analysed mRNA levels and 
alternative splicing patterns of alleles with and without the +14 bp using trophoblast biopsies. The 
allele, in which the 14 bp sequence is deleted belong to the G*01011 subgroup of alleles and the 
two different alleles examined that includes the +14 bp sequence belong to the G*01012 and 
G*01013 allele groups. When the expression of different HLA-G mRNA isoforms are compared in 
G*01011 and G*01012 heterozygotic samples, the overall HLA-G mRNA expression level is 
reduced with 30%-60% in that of the G*01012 allele where the +14 bp is present, compared to 
G*01011. Furthermore, in G*01012 transcription into mRNA, of the following isoforms, lacking 
the first 92 bp of exon 8, were observed; G1, G5 and G6 - but not the G2 and G4. The splicing 
pattern differed from the G*01013 which in addition produced G2 and G4 transcripts lacking the 92 
bp. The level of G1 from G*01013 was similar to G*01011 and the level of G2 and G4 was higher 
than that of G*01011, while G3 was nearly absent as also seen by O’Brien et al. [2001].  
The outsplicing of the 92 bp is likely to be caused by the +14 bp polymorphism and the shortening 
of the transcripts might possibly cause instability of the transcripts [Hviid et al. 2003]. This was 
investigated in a study by Rousseau et al. [2003] in which they compared the stability of the +92 
transcript in relation to the -92 from two +14 bp variants. They used JEG-3 cell line naturally 
expressing the +14 bp polymorphism from the G*010103 allele and M8 cell lines transfected with 
the +14 bp G*010102 allele. HLA-G transcription was blocked for up to 30 hours before extracting 
total RNA. From this, comparison could be made on the stability of the +92 and -92 transcripts. 
Curiously the results showed an unexpected increased stability of the -92 transcript. This is 
explained by Rousseau et al. [2003] with the presence of an AUUUG sequence in the +92 transcript 
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that is thought to stimulate decay of the mRNA. This motif is absent in the -92 transcript which 
could confer better resistance to mRNA degradation. This offers the possibility that the +14 bp has 
been an unknown advantage and therefore still has a high frequency in humans, even though it 
might confer a risk for developing PE [Rousseau et al. 2003]. How the +14 bp sequence can result 
in decreased levels of HLA-G protein in PE remains unexplained.      
 
Two Polymorphisms, Linked to the +14 bp Sequence, have been Associated with Pre-eclampsia  
Moreau et al. [2008] have investigated the allele distribution between offspring from pre-eclamptic- 
and control cases for eight allele groups: G*0101 to G*0107, and the +14 bp allele. The study 
included 36 pre-eclamptic placentas and 60 control placentas. Their results showed significant 
difference in the distribution of the G*0106 allele, between the two groups. This polymorphism is 
linked to the presence of the +14 bp sequence. The distribution in the fetuses was 21.2% for pre-
eclamptic cases vs. 6.6% for the controls [Moreau et al. 2008]. Tan et al. [2008] observed the same 
trend in a case-control study where the association between the G*0106 allele and the development 
of PE was investigated. The study included 83 pre-eclamptic cases and 240 normotensive Malay 
women and their infants. The women were further divided into two subgroups; primipara and 
multipara. The DNA samples were collected from whole blood, for analyses of the mother’s 
genotype and blood from the umbilical cord for analysis of the genotype of the offspring. Tan et al. 
[2008] did not observe any significant differences in allele distribution for the pre-eclamptic 
mothers and control cases but like reported by Moreau et al. [2008] the frequency of G*0106, both 
as heterozygote and homozygote, was higher in PE offspring compared to controls. However this 
was only found in multipara offspring in the study by Tan et al. [2008].  
Furthermore, the results of Tan et al. [2008] showed that the frequency of mother-child HLA-G 
genotype mismatches among multipara pregnancies, in which mothers were homozygous G*0106 
negative, and carried fetuses who were heterozygous for G*0106, was significantly higher in PE 
pregnancies. Tan et al. [2008] concludes that the presence of a G*0106 allele in the fetus increases 
the risk of PE. Furthermore they suggest an immunological basis for PE, because the results showed 
a higher frequency of G*0106 negative pre-eclamptic mothers with fetuses carrying paternally 
inherited G*0106, which might be detected as a foreign HLA-G variant by the mothers immune 
system. The primipara data from the aforementioned study by Hylenius et al. [2004] also showed 
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that the G*0106 allele, were slightly more frequent in pre-eclamptic triads (parents and offspring) 
than in controls. 
A single bp polymorphism, 1745ΔA, in the 3’UTR was tested for association with PE and in 
relation to HLA-G mRNA stability. The mutation is located at +1745 of the HLA-G gene in exon 8 
adjacent to an AUUUA motif, which is an AU-rich sequence mediating mRNA degradation [Yie et 
al. 2008]. The polymorphism is inherited in connection with the +14 bp polymorphism. Yie et al. 
[2008] recruited 29 PE patients and 15 healthy control cases from whom DNA from placental tissue 
was extracted and investigated. The obtained results showed a significant difference in allele 
distribution between offspring from the PE group and offspring from the control group with excess 
of the 1745ΔA allele in PE cases. Furthermore Yie et al. [2008] found, when dividing PE cases into 
severe and mild PE, that 12 out of 14 offspring from severe PE cases showed to be homozygous for 
the 1745ΔA variant while this was only observed in 4 out of 15 offspring of the mild PE cases.  
Yie et al. [2008] also tested whether a reduction in HLA-G protein level observed in PE was caused 
by the AUUUA motif adjacent to the 1745ΔA polymorphism. Their results showed that the HLA-G 
mRNA translated from the 1745ΔA allele decayed rapidly, when compared to HLA-G mRNA 
translated without the polymorphism. The results indicate that the 1745ΔA polymorphism could be 
involved in the decrease in HLA-G protein levels seen in PE. To get an overview of the different 
polymorphisms see Table 4.  
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Tabel 4: Different studies that have investigated the association between HLA-G polymorphisms and the risk of 
PE. In the column showing the number of PE/control subjects the number of primiparas and multiparas are 
presented if specified in the particular study. Furthermore it is written in parentheses whether only offspring, 
mothers, fathers or all three are included in the studies. 
Study PE/control subjects Result 
G*0105   
Aldrich et al. [2000] 57/36 (offspring) No association with PE in offspring 
Hylenius et al. [2004] 40 primiparas, 17 
multiparas/70 primiparas, 
28 multiparas (parents and 
offspring) 
No association with PE neither in parents 
or offspring 
G*0104   
Carreiras et al. [2002] 104/29 (mother and 
offspring) 
Association with PE when the allele was 
maternally inherited 
Hylenius et al. [2004] 40 primiparas, 17 
multiparas/70 
primiparas/28 multiparas 
(parents and offspring) 
No association with PE in either parents 
or offspring 
14 bp   
polymorphism   
Hylenius et al. [2004] 40 primiparas, 17 
multiparas/70 
primiparas/28 multiparas 
(parents and offspring) 
Association with PE in offspring and 
several +14 bp alleles in mother-child 
pair.Association with paternal 
inheritance. 
(only significant in primiparas) 
Vianna et al. [2007] 157/162 (mothers) A trend showing higher allele frequency of -14 bp in PE women 
Iversen et al. [2008] 31/43 (mothers and 
offspring) 
No association with PE in neither 
offspring or mother 
Bermingham et al. 
[2000] 
68 primiparas/ 74 
primiparas (parents and 
offspring) 
No association with PE in either parents 
or offspring 
Moreau et al. [2008] 36/60 (offspring) Association in PE offspring 
O’Brien et al. [2001] 
7/11 (offspring) Association in PE offspring 
G*0106   
Moreau et al. [2008] 36/60 (offspring) Association in PE offspring 
Tan et al. [2008] 83/240 (mother and 
offspring) 
Association in PE offspring when 
especially when paternally inherited 
(only significant in multiparas) 
1745ΔA   
Yie et al. [2008] 29/15 (offspring) Association in PE offspring 
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HLA­G and its Interaction with Immune Cells 
Different theories for tolerance of the fetus involving HLA-G have been proposed since the 
discovery of the molecule. Present paragraph gives an overview of existing branches of research on 
HLA-G's effect on different immune cells. HLA-G does not only have an impact on pregnancy 
outcome but is similarly important in connection to oncology and transplant graft acceptance. In 
transplantation, it has been shown that HLA-G expressed in the graft and/or the plasma results in 
significantly better graft acceptance [reviewed in Carosella et al. 2008].  
Some HLA-G isoforms are found to inhibit; 1) the cytolytic function of uterine and peripheral blood 
NK cells [Rouas-Freiss et al. 1997a; Rouas-Freiss et al. 1997b; Le Discorde et al. 2005], 2) the 
cytolytic function of antigen-specific cytotoxic T lymphocytes [Riteau et al. 2001; Contini et al. 
2003], 3) the alloproliferative response of CD4+ T cells [Bainbridge et al. 2000a], 4) the activated 
CD8+ T cells by apoptosis [Fournel et al. 2000; Contini et al. 2003], 5) the proliferation of 
peripheral blood T cells [LeMaoult et al. 2007; Bahri et al. 2006], 6) the alloreactive function of 
peripheral blood mononuclear cells and purified CD4+ T cells [LeMaoult et al. 2004], and 7) 
maturation and function of dendritic cells [Ristich et al. 2005]. 8) Furthermore an up-regulation of 
inhibitory receptors (ILT2, ILT3, and ILT-4) are seen in antigen presenting cells, T cells and NK 
cells as a result of HLA-G stimuli [LeMaoult et al. 2005] (See Table 5). 
 
       1 Inhibition of the Cytolytic Function of Decidual and Peripheral Blood NK cells by mHLA-G  
Regarding HLA-G inhibition of polyclonal peripheral blood NK cells, Rouas-Freiss et al. [1997a] 
separately evaluated membrane bound HLA-G1 and HLA-G2 isoforms. The study found that not 
only HLA-G1 but also the HLA-G2 isoform mediates the protective effect. Because HLA-G 
inhibited the NK lytic activity of all the human donors tested (20 donors) in the study, Rouas-Freiss 
et al. [1997a] suggest that HLA-G is a ligand for NK inhibitory receptors. The absolute level of NK 
lysis varied in the donors, but the sensitivity of HLA-G1 - and HLA-G2-expressing cells to the lysis 
was reduced by 70% or more. To verify whether HLA-G was a ligand for NK inhibitory receptors 
Rouas-Freiss and co-workers [1997b] demonstrated the role of HLA-G in immunological tolerance 
of cytotrophoblast cells ex vivo. Experiments were carried out in six semi-allogenic combinations 
(maternal dNK cells and their own fetal-derived trophoblast counterparts) and in 20 allogenic 
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combinations (maternal dNK cells and trophoblast cells isolated from different mothers). In both 
types of combinations of dNK cells and trophoblasts, the results showed that trophoblast cells 
expressing HLA-G inhibited dNK lysis.  
The fact that the dNK cell lytic activity were inhibited by both semi-allogenic and allogenic HLA-G 
on trophoblast cells gives an indication of the potential importance of HLA-G's role in pregnancy.  
Inhibition of NK cells lytic activity was also proven by [Riteau et al. 2001]. This study conducted 
cytotoxicity experiments and the outcome indicated that a transfection of HLA-G isoforms in M8 
cells leads to inhibition of polyclonal NK cells and NK clone lytic activity. Moreover, the study 
showed that HLA-G isoform-mediated NK lysis inhibition did not occur through HLA-E as 
proposed by previous reports [Lee et al. 1998b]. 
Furthermore truncated HLA-G isoforms are comparatively less expressed than the “complete” 
isoforms, HLA-G1 and HLA-G5. Nevertheless these have been proven functional in several 
instances, like in cases where people carry the HLA-G null allele; G*0105N. A study by Le 
Discorde et al. [2005] investigated the effect of HLA-G isoforms transcribed from the G*0105N 
allele in respect to peripheral NK cell function, in the absence of HLA-G1, -G5, and -G4. Here it 
was shown that the isoforms HLA-G2, HLA-G3, HLA-G6 and HLA-G7 was capable of protecting 
cells against NK cytolysis via NK cell inhibition. 
 
       2 Inhibition of the Cytolytic Function of Antigen-specific Cytotoxic T Lymphocytes by HLA-G  
HLA-G1 and sHLA-G1 are known to have similar functions. Other HLA-G isoforms have not yet 
been well studied; therefore little is known about their function [Carosella et al. 2008] except that 
HLA-G2, HLA-G3, and HLA-G4 can inhibit both NK cell and cytotoxic T lymphocyte cytolysis in 
vitro [Riteau et al. 2001]. Riteau et al. [2001] investigated both the biochemical and functional 
aspects of the other mHLA-G isoforms compared with those of HLA-G1. The study separately 
transfected cDNA of HLA-G1, -G2, -G3 and -G4 into HLA-A, -B, -C, and -E-positive M8 cell 
lines, which normally lacks HLA-G transcription. Afterwards stable transfectants were obtained for 
each HLA-G isoform. It was observed that HLA-G2, -G3 and -G4 reached the cell surface within 2 
hours after synthesis. Therefore, they suggest that all the isoforms used are potential inhibitors of 
NK cells and cytotoxic T lymphocytes. The findings of Riteau et al. [2001] could be of interest in 
situations where HLA-G1 expression is lowered, such as by mutations. In these cases it is likely 
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that the normally less expressed HLA-G2, -G3 and -G4 would be of particular importance 
maintaining a normal pregnancy. 
 
       3. Inhibition of the Alloproliferative Response of T cells by HLA-G 
A study by Bainbridge et al. [2000a] aimed to investigate the effect of HLA-G on T lymphocyte 
responses. To do this they used HLA class II-bearing HLA-G transfectants as stimulators of a mixed 
lymphocyte reaction, containing CD4+ T cells, CD8+ T cells and phagocytes. It was shown that 
HLA-G suppressed the proliferation of the lymphocytes. The results of the study suggest that HLA-
G exerts a direct suppressive effect on CD4+ T cells, but not on CD8+, because the anti-proliferative 
effect persisted after phagocytes and CD8+ T cells had been depleted from the mixed lymphocyte 
reaction. When CD8+ T cells were tested in a reaction without CD4+ T cells and phagocytes no 
proliferation was shown in both HLA-G transfected cells and in controls. Other human HLA class I 
molecules are thought to interact primarily with CD8+ cells. Nevertheless Bainbridge et al. [2000a] 
found that CD8+ T cells did proliferate during a reaction without depletion of CD4+ T cells, which 
could indicate that CD4+ T cells releases cytokines which stimulates CD8+ T cells proliferation. 
Hereby, CD8+ T cells can be thought to be secondary to, and dependent on, CD4+ T cells. Thus, 
HLA-G may allow the fetus to escape the acquired maternal immune response by suppressing CD4+ 
T cells activity [Bainbridge et al. 2000a]. 
Similar results were obtained by LeMaoult et al. [2007] who investigated whether HLA-G1 could 
be transferred from antigen-presenting cells to T cells and whether trogocytosis of HLA-G1 had 
functional significance. Trogocytosis is a transfer of membrane fragments, not of individual 
molecules, from one cell to another. LeMaoult and co-workers [2007] used peripheral blood 
mononuclear cells and found that most activated and some resting CD4+ and CD8+ T cells were 
suppressed by HLA-G1 via trogocytosis. The acquisition of HLA-G through membrane transfers 
immediately reversed the function of the T cells from being effectors to being regulatory cells. 
These regulatory cells might constitute an "emergency" immune suppression mechanism. This can 
be used by HLA-G-expressing tissues to protect themselves against immune aggression, by quickly 
increasing the number of regulatory HLA-G1-positive cells locally and spreading HLA-G1 
presence to a larger area and finally by blocking the function of any effector cell recruited to stop or 
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dampen the local immune reaction preventing damage to tissues near the HLA-G1-expressing cell 
[LeMaoult et al. 2007]. 
 
       4. Inhibition of the Activated CD8+ T Cells by HLA-G Induced Apoptosis 
Fournel et al. [2000] reported that purified sHLA-G5 triggered in vitro apoptosis in activated, but 
not resting CD8+ peripheral blood T cells. By comparison only slight or no apoptosis was found 
when sHLA-B7 was used. Present study found that 50% of the activated CD8+ T cells were killed 
by sHLA-G5, compared with 100% killing if monoclonal antibodies against Fas receptor were used.  
       5. Inhibition of the Proliferation of Peripheral T Cells by HLA-G 
HLA-G's role in inhibition of T cell proliferation derived from peripheral blood leukocytes has been 
investigated by Bahri et al. [2006]. The suggestion that HLA-G regulates T cells was proposed 
because of the expression of HLA-G in the thymic epithelium [Bahri et al. 2006], which is the area 
of T lymphocyte maturation. Bahri et al. [2006] did not find HLA-G induced T cell apoptosis, as 
previous studies have found [Fournel et al. 2000; Contini et al. 2003], but found an inhibited T-cell 
proliferation as well as inhibited cell cycle progression, using HLA class I-positive M8 cells. The 
lack of induced caspase activity, and the lack of induced apoptosis observed in the study could be 
due to the fact that Bahri et al. [2006] investigated the early events of HLA-G-related inhibition of 
T cell proliferation, and therefore a later induction of T cell apoptosis cannot be excluded [Bahri et 
al. 2006]. The initial inhibition of the T cell proliferation by sHLA-G5 is due to the arrest of the cell 
cycle progression of T lymphocytes. Activation of T cell receptors are regulated by a protein called 
cyclin-dependent kinase inhibitor 1B (p27kip1), which is found in large amounts in resting T cells 
[reviewed in Bahri et al. 2006]. As T cells enter cell cycle, the amount of p27kip1 decreases. Bahri 
et al. [2006] observed more p27kip1 in T cells in the presence of HLA-G5 than in control cells, 
again suggesting an immune modulatory effect of HLA-G. 
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       6. Inhibition of the Alloreactive Function of Peripheral Blood Mononuclear Cells by HLA-G 
The aim of another study was to investigate whether HLA-G1-transfected antigen presenting cells 
were cells with a suppressive function. The immune cells used in the study were obtained from 
peripheral blood. The results showed that HLA-G1-transfected antigen-presenting cells strongly 
inhibited the allogeneic response of peripheral blood mononuclear cells and purified CD4+ T cells 
[LeMaoult et al. 2004]. In an immune response the interaction between antigen-presenting cells and 
CD4+ T cells leads to activation and proliferation of antigen-specific CD4+ T cells. By making the 
CD4+ T cells unable to respond to further stimulation, HLA-G1-transfected antigen-presenting cells 
might hereby induce a long-term unresponsiveness and promote the differentiation and maturation 
of CD4+ T cells into suppressor cells [LeMaoult et al. 2004]. This will again be beneficial for a 
successful pregnancy. 
 
       7. Inhibition of the Maturation and Function of T cells through HLA-G Interaction with DCs 
DCs are shown to play a critical role in the control of the innate and adaptive immune system. This 
cell type is present in the maternal decidua where they through ILT2 and ILT4 inhibitory receptors 
interact with T cells. The expression of ILT on DC is controlled by inflammatory stimuli, cytokines, 
and growth factors and the expression is down-regulated after DC activation. HLA-G, being a 
ligand for ILT2 and ILT4, might play an important role in the control of DC activation, maturation 
and differentiation, leading to development of tolerogenic DC. Ristich et al. [2005] used peripheral 
CD14+ monocytes and demonstrated that DC plays a part in induction of antigen-specific 
unresponsiveness or tolerance of T cell responses. In vivo experiments on mice found that 
interaction of HLA-G with ILT4 expressed on DC prolonged allograft survival, and this survival 
was associated with down-regulation of T cell activation and the development of T cell anergy, both 
situations beneficial in pregnancies [Ristich et al. 2005]. 
 
       8. Up-regulation of Inhibitory Receptors (ILT2, ILT3, and ILT-4) are seen in Antigen 
Presenting Cells, T cells and NK Cells as a Result of HLA-G Stimuli  
LeMaoult et al. [2005] investigated whether HLA-G is responsible for up-regulation of inhibitory 
receptors expressed on antigen presenting cells, NK cells, and T cells. The study showed that HLA-
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G1-transfected antigen presenting cell lines had a higher cell surface expression of ILT2, ILT3, and 
ILT-4 mRNA than nontransfected cells. In connection with this, they found that it was HLA-G1 or 
sHLA-G5 that up-regulated the inhibitory receptors on antigen-presenting cells, monocytes, NK 
cells and CD4+ T cells. This up-regulation might lead to increased sensitivity of "responder" cells to 
inhibition by tissue expressing HLA-G. Since ILT2, ILT3, and ILT-4 have other ligands than HLA-
G, it might also lead to increased sensitivity of "responder" cells to inhibition by for instance 
classical HLA class I molecules, such as HLA-C which are also found in placenta. The increase in 
inhibitory receptors might be an advantage because HLA-G-expressing tissue, such as the placenta 
is potential targets for NK cells and cytotoxic T lymphocytes.  
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Tabel 5: HLA-G functions. When present table does not specify which type of HLA molecules or NK cells the 
different studies used, this is because it was not indicated by the studies. None of the T cells obtained from the 
studies presented in this table w 
HLA-G function  Isoforms Effector cells Reference 
Inhibition of cytotoxic 
function 
HLA-G1 and -
G2 
 
Polyclonal CD3- CD16+ 
CD56+ NK cells 
[Rouas-Freiss et al. 
1997a]  
 
 HLA-G1 CD56+ CD16- dNK cells [Rouas-Freiss et al. 
1997b] 
 HLA-G2, -G3, -
G6, and -G7 
NK cells [Le Discorde et al. 2005] 
 HLA-G2, -G3,  
and -G4 
Peripheral NK cells  [Riteau et al. 2001] 
Up-regulation of 
inhibitory receptors 
HLA-G1 and -
G5 
NK cells [LeMaoult et al. 2005] 
Apoptosis 
 
sHLA-A,- B, -C, 
and HLA-G1 
CD8+ NK cells  [Contini et al. 2003] 
Inhibition of cytotoxic 
function 
HLA-G2, -G3, 
and -G4 
CD8+ cytotoxic T 
Lymphocyte 
[Riteau et al. 2001] 
Suppression of cell 
activity 
HLA-G CD4+ T cells [Bainbridge et al. 2000a] 
 HLA-G1 Activated CD4+ and 
CD8+ T cells 
 [LeMaoult et al. 2007]                                              
Apoptosis HLA-G1 CD8+ T cells [Fournel et al. 2000]  
 sHLA-A,- B, -C, 
and HLA-G1 
CD8+ T cells  [Contini et al. 2003] 
Up-regulation of 
inhibitory receptors  
sHLA-G and 
mHLA-G 
CD4+ T cells [LeMaoult et al. 2005] 
Inhibited 
proliferation 
sHLA-G5 CD4+ and CD8+ T cells [Bahri et al. 2006] 
Inhibition of 
development/immune 
response 
HLA-G1 CD4+ T cells [LeMaoult et al. 2004] 
DC induction of 
anergic and 
immunosuppression 
HLA-G CD4+ and CD8+ T  cells [Ristich et al. 2005]   
 
From all of this it is found that sHLA-G and/or mHLA-G indeed have an inhibitory effect on 
immune cells such as NK cells and T cells. Since 70% of the immune cells of the placenta are NK 
cells [reviewed in Tabiasco et al. 2006], the effect of HLA-G on NK cells is likely to have impact in 
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establishing a normal pregnancy. Furthermore, it seems that T cells also play a crucial role in 
regulating the immune system even though no studies have been made regarding interaction 
between HLA-G and T cells derived specifically from the placenta.  
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HLA­C and Pre­eclampsia 
The relation between PE and HLA-C has not been as extensively studied as the relation with HLA-
G, however, interesting results about the interaction with dNK cells have been obtained with HLA-
C both through immunogenetic, epidemiological and functional studies. 
Immunogenetic Studies Regarding HLA­C and Pre­eclampsia 
A study of Hiby et al. [2004] addressed HLA-C in respect to development of PE. The reason for 
studying HLA-C in this context was that it is expressed on extravillous trophoblast cells and it is the 
only HLA-gene expressed on extravillous trophoblast cells that is highly polymorphic, which means 
that this gene could potentially lead to an immune response during pregnancy because of the 
presentation of foreign antigens to the maternal immune system.  
As described in paragraph “The Function of NK Cells in Relation to HLA Molecules” dNK cells in 
humans express KIR receptors that binds HLA-C. The binding of HLA-C to KIR can deliver an 
inhibitory signal as well as an activating signal to the NK cell, depending on the type of KIR. 
Furthermore dNK cells have been shown to express KIRs that specifically bind HLA-C at a higher 
level compared to pheripheral NK cells [Verma et al. 1997]. Therefore, Hiby et al. [2004] tested a 
hypothesis stating that binding of HLA-C molecules to KIR on dNK cells play an important role in 
the development of PE. 
There are overall two groups of KIR haplotypes, called A and B. The A haplotype mainly has 
inhibiting receptors, while the B haplotype has more loci than the A haplotype and these mainly 
code for additional activating receptors. In the study of Hiby et al. [2004] the subjects were 
separated as those having an AA genotype and those having an AB or BB genotype.  
The HLA-C genotypes can also be divided into two groups: C1 and C2 where the difference is a 
dimorphism in the α1-domain. This enables the KIR to distinguish between the two different 
epitopes. C1 is the main ligand for the inhibitory KIR2DL2/3 and the activating KIR2DS2, while 
C2 is a ligand for the inhibitory KIR2DL1 and the activating KIR2DS1. Possibly other KIRs also 
bind HLA-C. 
Overall, the KIR and HLA-C provide two polymorphic gene systems at the maternal-fetal interface. 
Hiby et al. [2004] compared the KIR and HLA-C genotypes in 200 women affected by PE with 201 
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women having normal pregnancies. Hiby et al. [2004] found that the frequencies of different HLA-
C polymorphisms were equal in both mother and fetus, when pre-eclamptic pregnancies were 
compared to controls. This indicates that HLA-C cannot be the only factor determining a change in 
risk of PE. However, women having two KIR A haplotypes were significantly overrepresented in 
the group of women affected by PE, where 35% showed this haplotype compared to 25% in 
controls [Hiby et al. 2004]. However, further research showed that this increased frequency was 
related to subjects where the fetus expressed HLA-C2. The study found that it was irrelevant 
whether the fetus was heterozygote or homozygote regarding HLA-C2. In women affected by PE 
and where the fetus only expressed HLA-C1, a higher frequency of the AA genotype in the mothers 
was not observed. 
The findings of Hiby et al. [2004] show, that some combinations of maternal KIR and fetal HLA-C 
genotypes increase the risk of PE. When the maternal AA genotype occurs together with a 
heterozygote or homozygote HLA-C2 genotype of the fetus it appears to increase the risk of PE 
significantly (see figure 11). However, PE can also develop in women in whom this combination is 
not present.   
 
Figure 11: The findings of Hiby et al. [2004] show that some combinations of maternal KIR and fetal HLA-C 
genotypes increase the risk of PE. When the maternal AA genotype occurs together with a heterozygote or 
homozygote HLA-C2 genotype of the fetus it appears to increase the risk of PE significantly, which is assembled 
by a tick [modified from Moffet & Hiby 2007, pp. 53]. 
 
To clarify whether the interaction between HLA-C and KIR was part of an immune response, Hiby 
et al. [2004] compared the fetal HLA-C genotypes with the HLA-C genotypes of the mothers to 
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elucidate whether the shown connection was due to a maternal immune reaction against a foreign 
HLA-C from the fetus. No significant difference was observed in the number of pre-eclamptic 
pregnancies, where the fetus expressed a foreign HLA-C or did not express all of the same HLA-C 
allele as the mother, when compared to controls. This leads to rejection of the hypothesis that PE 
develops because of semi-allogenic HLA-C molecules.   
The theory on how the interaction between HLA-C and KIR can be important in the pathogenesis of 
PE is that when the fetus has a HLA-C2 allele, the dNK cells expressing KIR AA genotype will be 
inhibited, because the A haplotype mainly has inhibitory KIR receptors. This might inhibit the 
cytokine secretion from NK cells which are believed by some to facilitate the normal trophoblast 
invasion, as described later in this paragraph. If the NK cells are not activated it can potentially 
cause inadequate trophoblast invasion, resulting in PE. The reason why C1 does not cause the same 
inhibition of the A haplotype of KIR is suggested by Hiby et al. [2004] to be caused by weakly 
binding of HLA-C1 to its corresponding inhibitory KIR2DL2/3 compared to HLA-C2 binding to 
KIR2DL1. Therefore, C1 cannot inhibit the NK cell to the same degree as C2. Hiby et al. [2004] 
suggest that when C2 is present together with the KIR B haplotype the activating KIR in this 
haplotype might neutralize the inhibitory signal in some way. 
In support of this hypothesis, research has shown that dNK cells produce noticeable amounts of 
chemokines and angiogenic cytokines [Hanna et al. 2006] (see paragraph “HLA-C and Pre-
eclampsia”). This leads to the hypothesis that NK cells might act through their cytokine release in 
controlling pregnancy instead of functioning via their cytotoxic mechanism. Therefore, the way 
HLA class I molecules can inhibit cytotoxic NK cell activity might not be the important mechanism 
in pregnancy, and the activating KIR might not only activate the cytotoxic killer function, but 
activate a certain production of cytokines which could induce invasion of trophoblasts. This could 
explain why the NK cells have activating receptors for HLA class I molecules. 
For further investigation of the connection between HLA-C2 and KIR AA genotype, Hiby et al. 
[2004] studied the gene frequencies of HLA-C2 and KIR AA in different populations. They obtained 
most of the data from different cohorts in various populations. They found that the two genotypes 
are inversely associated, so in most populations there is not a high frequency of the one genotype 
together with the other, and this might be because of the complications it potentially leads to. That 
is, the specific combination is unfavourable and has been selected against during evolution. Hiby et 
al. [2004] found that for instance the frequency of the KIR AA genotype is very high and the HLA-
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C2 frequency is very low in Japanese people, whereas Caucasians show moderate frequencies of 
both genotypes. 
Epidemiological Studies, HLA­C and Pre­eclampsia 
According to the hypothesis proposed by Hiby et al. [2004] a Japanese woman getting pregnant 
with a Caucasian man would have a higher risk developing PE than a Japanese woman getting 
pregnant with Japanese man. Saito et al. [2006] have studied this hypothesis by analysing the risk 
of PE in 324 couples consisting of Japanese women and Caucasian men. As control they used a 
Japanese database with data from 36,829 pregnant women, however, the nationality of the pregnant 
women and their men was not available from this database, and Saito et al. [2006] assumed that 
98% of the couples consisted of Japanese women and Japanese men. Saito and colleagues [2006] 
only studied singleton pregnancies, and furthermore the study group and the control group have 
more or less the same frequency of primiparas which has been associated with an increased risk of 
PE, as described in paragraph “Risk Factors for the development of Pre-eclampsia. 
Saito et al. [2006] found that there were no significant differences in the prevalence of PE between 
the study group (1.54%) and controls (2.67%). Therefore, the investigation of Saito et al. [2006] 
cannot support the hypothesis presented by Hiby et al. [2004] because the theoretical increase in 
fetal genotype HLA-C2 together with a high frequency of genotype KIR AA of the mother did not 
lead to a higher risk of PE. However, Saito et al. [2006] have not studied the exact genotypes of 
their study subjects. 
Functional Studies Regarding dNK Cells in Relation to Trophoblasts, HLA­C, 
and HLA­G 
Hanna et al. [2006] have studied human dNK cells and their role in pregnancy, especially their 
interaction with trophoblast cells and the reason why they do not kill the semi-allogenic cells.  
The study examined which factors were released from dNK cells to examine whether some of these 
factors could possibly have an impact on pregnancy. From a micro-array analysis of human dNK 
cells it was found that dNK cells secrete a relatively large amount of angiogenic and endothelial 
mitogenic stimulants such as isoforms of vascular endothelial growth factor (VEGF) and placental 
growth factor (PLGF). Decidual NK cells also expressed chemokines such as IL-8, and interferon-
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inducible protein (IP)-10. Compared to peripheral blood derived NK cells, dNK cells secreted far 
more of VEGF, PLGF, IL-8 and IP-10, so this might lead to a special function of dNK cells. 
Even though human dNK cells produce chemokines and angiogenic factors the trophoblast cells 
need to have receptors for these secretion factors if they are supposed to have an effect on 
trophoblast cell invasion. Therefore, the expression of receptors on trophoblast cells was examined 
and it was observed that for instance Chemokine Receptor 1 (CXCR) and CXCR3 were expressed 
on the trophoblast cells among a range of other receptors. IL-8 is believed to be a ligand for CXCR1 
and IP-10 is the ligand for CXCR3 and those two were the only receptors found for cytokines 
secreted by dNK cells. The other receptors found on trophoblast cells do not correspond to factors 
secreted by dNK cells. Therefore it is possible that dNK cells communicate with trophoblast cells 
via CXCR1 and CXCR3. 
Hanna et al. [2006] hereafter made an experiment where different NK cells were incubated with 
isolated human trophoblast cells in a Matrigel. The cells were incubated for five days, and then the 
trophoblast cells that had migrated in the Matrigel were counted. The amount of trophoblast cells 
that had migrated were correlated to the amount of IL-8 and IP-10 because the trophoblast cells 
mainly migrated in the presence of dNK cells and not peripheral blood NK cells, and furthermore 
this migration was inhibited when IL-8 and IP-10 was down-regulated via antibodies against IL-8 
and IP-10. These results were furthermore confirmed by in vivo studies in mice.  
From these studies it can be speculated that NK cells regulate trophoblast invasion by IL -8 and IP-
10 chemokines via the trophoblast receptors CXCR1 and CXCR3. 
Decidual NK Cells and HLA Class I Molecules 
The interaction of dNK cells and HLA class I ligands were also examined by Hanna et al. [2006]. 
The secretion of growth factors by dNK cells with different KIR profiles was analysed. Decidual 
NK clones that expressed the activating KIR2DS4 receptor secreted large amounts of growth factor 
(VEGF, PLGF, IL-8 and IP-10), when they were incubated with cells transfected with the member 
of  the HLAC2 group, HLA-Cw4, but not when they were incubated with cells transfected with 
HLA-Cw6 and the control: mock-transfected cells. Decidual NK cells expressing the inhibitory 
receptor KIR2DL1 had lower secretion of growth factors when transfected with HLA-Cw4 or HLA-
Cw6 than if incubated with mock-transfected cells. Both HLA-Cw4 and HLA-Cw6 belong to the 
HLA-C2 group [reviewed in Yokoyama & Riley 2008]. 
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Apart from KIR, the inhibitory ILT2 receptor expressed on dNK cells were also analysed. Ig-like 
transcript 2 is believed to bind both classical and non-classical HLA, such as for instance HLA-G as 
described in paragraph XX. Decidual NK clones expressing ILT2, were incubated with cells 
transfected with HLA-G and this inhibited the secretion of cytokines from dNK cells, but this was 
not observed if dNK cells were incubated with cells transfected with HLA-Cw4 or HLA-Cw6. 
Hanna et al. [2006] suggest that this can be explained by ILT2 having a much higher affinity for 
HLA-G than HLA-C. 
The experiments made by Hanna et al. [2006] hereby support a hypothesis that HLA-C and HLA-G 
bound to inhibiting receptors reduce trophoblast invasion by inhibiting the secretion of growth 
factors by NK cells, but different HLA-C types affect various KIR receptors differently. Hanna et 
al. [2006] also show that the observed secretion of angiogenic factors by dNK cells promotes 
vascular growth and maybe this is the exact mechanism which is inhibited by binding of HLA-C 
and HLA-G to inhibiting NK cell receptors, and it might be one of the causes of PE, however, this 
is controversial and will be discussed further in paragraph “HLA-G and its Interaction with Immune 
Cells”.  
Furthermore, it has been proposed that invasive trophoblast cells are capable of attracting the 
special decidual NK cells to the deciduas by secreting special chemokines [Hanna et al. 2003], and 
therefore a close interaction between trophoblast cells and dNK cells might exist. 
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The Involvement of HLA­E and HLA­F in Pre­eclampsia 
HLA-E was originally only detected intracellularly, and was therefore believed to be incapable of 
being expressed on the cell surface, and thus incapable of displaying extracellular function [Shimizu 
et al.1988]. However in later it was shown that HLA-E, in contrast to other HLA class I molecules, 
required binding of leader peptides derived from other HLA class I molecules, and not common 
peptides derived from intercellular proteins, to be expressed on the cell surface [Braud et al. 1998]. 
Since this discovery, data about the function of HLA-E has accumulated. In regard to the HLA-F 
gene, not much research has been made, and only recently a few studies about the HLA-F protein 
expression have appeared [reviewed in Ishitani et al. 2006].  
Interaction of HLA­E with CD94/NKG2 Receptors on NK Cells 
It was shown in 1998 that HLA-E/peptide complexes, with leader peptides derived from class Ia 
molecules (HLA-E/Ia), interact with CD94/NKGA receptors on NK cells derived from peripheral 
blood, which leads to inhibition of the killing activity of the NK cells [Borrego et al. 1998; Lee et 
al. 1998b]. Furthermore, Llano et al. [1998] showed that HLA-E/peptide complexes, with leader 
peptides derived from HLA-G (HLA-E/Gpep), interacted with the CD94/NKGC receptor and 
activate the cytotoxicity of peripheral blood NK cells. However, it was shown that HLA-E/Gpep 
also exhibit an inhibitory effect on NK cells through interaction with the inhibiting NK cell 
receptor, CD94/NKGA, which is also supported by Kaiser et al. [2005] and Valés-Gómez et al. 
[1999] (see figure 12). The HLA molecules expressed on the trophoblast cells are, as mentioned 
earlier in the paragraph “Human Leukocyte Antigens”, limited to the non-classical molecules, 
HLA-G, -E and –F, with the exception of the classical HLA-C. Therefore, HLA-E on throphoblast 
cells mainly bind leader peptides derived from HLA-G, but can also weakly bind peptides derived 
from HLA-C (HLA-E/Cpep), while leader peptides from HLA-F cannot be bound by HLA-E [Lee 
et al. 1998a, Valés-Gómez et al. 1999]. T cells are are devided into αβ T cells and γδ T cells. 
Barakonyi et al. [2002] investigated the function of HLA-E on γδ T cells, which is significantly 
increased in number in both the decidua and peripheral blood in healthy pregnant women compared 
with non-pregnant women and women with recurrent abortions [reviewed in Szekeres-Bartho et al. 
2001]. The γδ T cells are divided into two subpopulations; the mainly cytotoxic Vγ9/Vδ2 
subpopulation and the Vγ4/Vδ1 subpopulation, last-mentioned acting in a TH2 like manner. The 
decidual T cells mainly interact through the Vγ4/Vδ1 receptor, while peripheral blood of non-
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pregnant women mainly contains T cells with the cytotoxic Vγ9/Vδ2 receptor [reviewed in 
Szekeres-Bartho et al. 2001]. However, in healthy pregnant women, the peripheral blood, similar to 
decidua, preferentially has the Vγ4/Vδ1 receptor [reviewed in Szekeres-Bartho et al. 2001]. Results 
from Barakonyi et al. [2002] showed that the cytotoxic Vγ9/Vδ2 T cells recognize HLA-E on 
trophoblasts. However it was also shown that, CD94 normally presented on NK cells, also is 
expressed on the majority of circulating γδ T cells and when treated with blocking concentrations of 
anti-CD94 against HLA-E transfected cells, an increased cytotoxic activity was observed. These 
results indicate that the cytotoxicity of Vγ9/Vδ2 T cells can be inhibited via HLA-E interacting with 
CD94 located on γδ T cells (see figure 12) [Barakonyi et al. 2002]. 
The finding of homozygotes of the HLA-G null allele, G*0105N, in non-pre-eclamptic individuals 
suggests that HLA-G is not essential for a healthy pregnancy. However, Sala et al. [2004] 
discovered that G*0105N was able to provide leader peptides to HLA-E, and thus be presented on 
the cell surface through interaction with HLA-E [Sala et al. 2004], which underlines the role of 
HLA-E. Furthermore, it was shown that HLA-E in complex with leader peptides derived from the 
G*0105N allele had the capacity to interact with CD94-NKG2A [Sala et al. 2004]. 
 
Figur 12: This figure illustrates the interaction of HLA-E/Gpep, HLA-E/Cpep and HLA-F on extravillous 
trophoblasts with maternal decidual T-cells and maternal NK cells [modified from Ishitani et al. 2006].  
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Expression of the Non­Classical HLA Molecules During Pregnancy 
Shobu et al. [2006] investigated the expression pattern of HLA-F on the surface of extravillous 
trophoblast cells during a normal pregnancy, comparing with the expression of HLA-G and -E. The 
results showed that HLA-F was expressed only in the cytoplasm of extravillous trophoblast cells 
during the first trimester, after which expression on the cell surface was detected and increased with 
the progression of pregnancy. HLA-E showed the same increasing expression pattern, but unlike 
HLA-F, it was expressed on the cell surface on extravillous trophoblast cells during the first 
trimester, and increased in expression from around the 20th weeks of gestation. HLA-G displayed a 
strong expression at all stages of the pregnancy both in the cytoplasm and on the cell surface 
[Shobu et al. 2006]. 
The strong and constant expression of HLA-G on extravillous trophoblast cells from early gestation 
to term supports the idea of HLA-G playing an important role in the protection of fetal tropoblast 
cells from maternal immune cells. The expression pattern of HLA-E resembles that of HLA-F, 
which may indicate a linked function between these in pregnancy. The increase of HLA-E 
expression on extravillous trophoblast cells from the 20th weeks of gestation is correlated with the 
time of rapid increase in fetal body weight. This increase in HLA-E expression could enhance the 
cytokine production from NK cells, and thereby may function to prepare the environment for fetal 
growth, see paragraph “HLA-C and Pre-eclampsia” [Shobu et al. 2006]. HLA-F has been shown to 
interact with ILT2 and ILT4 [Lepin et al. 2000], however, it has not yet been shown that HLA-F 
interacts with NK cells, so it is not clear whether HLA-F display an inhibitory effect on NK cells 
[Shobu et al. 2006]. 
Besides investigating the expression pattern of HLA-G, -E and -F during a normal pregnancy, 
Shobu et al. [2006] also compared the expression in placentas derived from normal occurring 
pregnancies with pre-eclamptic placentas. The result of these measurements showed a decreased 
expression of all of the non-classical molecules in pre-eclamptic placentas. However, the decrease 
in expression was due to necrotic extravillous trophoblasts while intact extravillous trophoblasts 
showed the same expression intensity in pre-eclamptic placentas as in normal placentas. These 
results suggests that a decrease in expression of HLA-G, -E and -F is a consequence of necrosis, 
and thereby a decrease in expression is not the cause of PE. Colbern et al. [1994] showed a decrease 
in expression in regard to HLA-G, however,   this decrease seems to be caused by a reduced number 
of trophoblasts in pre-eclamptic women, which support the findings of Shobu et al. 
The Implication of HLA Molecules in Pre-eclampsia 
Bachelor project in Medical Biology 76 
[2006][reviewed in Hviid et al. 2006a]. These results, however, are in contrast to results obtained 
from Goldman-Wohl et al. [2000] who showed a down-regulation in HLA-G in pre-eclamptic 
placentas compared to controls that were not due to necrosis (see paragraph “HLA-G 
Polymorphisms and Association with Pre-eclampsia”) In addition Lim et al. [1997] studied 
trophoblast cells from pre-eclamptic placentas, which failed to up-regulate both HLA-G mRNA and 
protein expression. 
Until now the specific interaction of relevant HLA molecules in PE have been described. In the 
following paragraphs two more general mechanisms involved in development of PE will be in 
focus: the TH1/TH2 response and tolerance induction. These two issues are relevant because of their 
close connection to regulation of the immune system during pregnancy and due to research showing 
that HLA-G is also involved in these regulatory mechanisms and hereby development of PE. 
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The Association Between HLA­DR and Pre­eclampsia 
HLA-DR expression is normally absent in the placenta (see paragraph “Human Leukocyte 
Antigens”), however, a former study by de Luca Brunori and colleagues in 1994 detected a 
widespread and intense HLA-DR expression in placentas derived from pre-eclamptic women, while 
HLA-DR expression was absolutely absent in control placentas [reviewed in de Luca Brunori et al. 
2000]. The placenta functions as an immunological barrier between the mother and the fetus, but 
during pregnancy this barrier becomes incredibly thin [Jones & Fox 1991]. Since HLA-DR 
normally is absent in the placenta, it can be speculated, that if somehow this thin barrier should be 
damaged, maternal and fetal blood could be mixed and possibly trigger a maternal rejection reaction 
caused by the presence of HLA-DR in pre-eclamptic placentas.  
Apart from the observation of HLA-DR expression in PE placentas, an association between variants 
of the HLA-DR locus and the occurrence of PE has been observed. The studies by Kilpatrick et al. 
[1989] and de Luca Brunori et al. [2000], determined maternal HLA-class II allele frequencies and 
discovered that the DR locus was implicated with statistically significant differences in allelic 
frequencies among pre-eclamptic cases and control cases. In particular there was an association 
between PE and the occurrence of the HLA-DR4 allele [Kilpatrick et al. 1989]. de Luca Brunori et 
al. [2000] further investigated partner homozygosity in a medium-sized study. The results showed a 
highly significant (P < 0.000001) increase in HLA-DR homozygosity in PE cases. When one of the 
parents was homozygote for HLA-DR and the other was heterozygote, or if both partners showed 
HLA-DR homozygosity the risk for PE was increased, when compared to the control couples. This 
means that in cases where both partners were heterozygotes, no association with PE was found.   
However since HLA-DR have not been found on trophoblast cells in the beginning of pregnancy, it 
is not likely that HLA-DR play a part in the initiation of PE, and therefore it is not a main focus in 
this project. HLA-DR might be important in the connection between the development of PE and the 
symptoms observed later.  
Until now the focus has been on specific HLA molecules. In the next paragraphs general 
immunologic mechanisms related to PE will be presented, this being induction of tolerance and TH1 
and TH2 response. 
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TH1 and TH2 Response and Pre­eclampsia in Relation to HLA­G 
As described in the paragraph “Reproductive Immunology – The Fetus is a Tolerated allograft” one 
hypothesis states, that the immune system is suppressed during pregnancy by changing the overall 
balance of the TH cells. It has been observed that normal pregnancy is related to an overall TH2 
response and down-regulation of the TH1 cells, hereby inhibiting the cell mediated immunity. These 
events are thought to be a critical step in a successful pregnancy. In favour of the TH1/TH2 model is 
the observation that diseases which are caused by a TH1 type response as autoimmune diseases such 
as rheumatoid arthritis are suppressed during pregnancy, and diseases due to intracellular infections 
gets worse, probably because the TH1 response that normally inhibit these diseases are suppressed 
in pregnancy because of the overbalance of a TH2 response [Moffett & Loke 2006; reviewed in 
Sargent et al. 2006]. 
The knowledge about changes in TH1/TH2 response during pregnancy results from measurements of 
the cytokine secretion of peripheral blood mononuclear cells. A change of the balance has been 
observed in PE, where the TH2 response is not as dominant as in normal pregnancy, instead an 
increase in TH1 cytokines has been observed [Dong et al. 2005; Germain et al. 2007; reviewed in 
Sargent et al. 2007]. When measuring the TH1/TH2 response in peripheral blood mononuclear cells 
the result is mostly relevant in the search for a reason for the systemic symptoms and inflammation 
observed in PE. It does not necessarily predict what is happening during the initiation of the 
syndrome where incomplete trophoblast invasion is seen. However, other researchers have 
measured the cytokine profile specifically in placenta.  
Dong et al. [2005] are some of the researchers that have shown a change in TH1/TH2 balance in PE 
compared to normal pregnancy by measuring placental levels of cytokines. They showed that the 
placental level of the TH1 cytokines IL-2 and TNF-α increased slightly in pre-eclamptic cases, 
whereas the level of the TH2 cytokine IL-10 decreased, but these results did not reach significance. 
However, the ratio of IL-2/IL-10 and the ratio of TNF-α/IL-10 showed a statistical significant 
increase in PE compared to normal pregnancy. Therefore the absolute level of the cytokines showed 
not to be relevant from this experiment, rather the ratio between different types of cytokines showed 
to be important in identifying changes correlated with PE. The expression of the individual 
cytokines in placenta is however controversial and studies have obtained different results [reviewed 
in Dong et al. 2005].  
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The idea of the TH1/TH2 balance has also been related directly to trophoblast function. Yui et al. 
[1994] have shown that TH1 cytokines such as TNF-α and IFN-γ probably inhibit trophoblast cell 
invasion because of induction of apoptosis in trophoblast cells. This finding might lead to a link 
between the first step in PE and the symptoms observed later, if the TH1 response is influencing 
both. 
Specifically HLA-G has also been associated with the regulation of TH1/TH2 balance. Maejima et 
al. [1997] have observed that HLA-G plays a part in regulating the cytokine secretion by peripheral 
blood mononuclear cells. These cells were cultured in the presence of target cells expressing HLA-
G, and it was found that they had an increase in IL-3 and IL-1β secretion and a decrease in TNF-α, 
which is thought to be beneficial for a successful pregnancy [Maejima et al. 1997]. 
Kapasi et al. [2000] have observed that the level of HLA-G influences the response in allo-
cytotoxic T lymphocytes and the cytokine secretion. The larger concentrations of HLA-G (> 0.1 
µg/ml) inhibited the allo-cytotoxic T lymphocyte response, while smaller concentrations (0.01-0.05 
µg/ml) enhanced the allo-cytotoxic T lymphocyte response in a mixed lymphocyte culture system. 
Concentrations of HLA-G below 0.01 µg/ml did not have any effect. Furthermore Kapasi et al. 
[2000] showed that in the suppressive concentrations of HLA-G the cytokine response measured in 
the mixed lymphocyte culture system was representing a TH2 response with increase in IL-10 and 
decrease in TNF-α and IFN-γ. And the concentrations stimulating allo-cytotoxic T lymphocyte 
response changed the cytokine secretion towards a TH1 type of response, where a decrease in IL-10 
and increase in TNF-α and IFN-γ were observed. These findings indicate that HLA-G and the 
concentration of it might be important in regulating the immune response during pregnancy and in 
regulating the TH1/TH2 balance. 
In recent research it has been questioned whether it is the TH cells that controls the cytokine balance 
between TH1 and TH2 responses, because some have suggested that NK cells are the main factors 
[Borzychowski et al. 2005]. Few studies have actually identified the cells responsible for the change 
in cytokine profile towards the TH1 response observed in PE. Instead they have assumed that it was 
a change in TH cell secretion due to a general thought about the TH1/TH2 balance. It has been 
observed that not only TH cells can be divided into a type 1 and type 2 response but also other 
lymphocytes can be divided into type 1 and type 2 subgroups [Borzychowski et al. 2005]. 
Borzychowski et al. [2005] observed in accordance with previous studies that PE had a higher 
percentage of circulating type 1 lymphocytes in total, compared to normal pregnancy, but when 
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examining the lymphocytes individually, they found no difference in the TH1/TH2 ratio in normal 
pregnancy compared to pre-eclamptic pregnancy in regard to TH cells derived from peripheral blood 
lymphocytes. Furthermore, they did not see any difference in the cytokine balance in TC cells, but 
the cytokine profile of NK cells were significantly changed in PE compared to normal pregnancy. 
The NK1/NK2 ratio was decreased in normal pregnancy compared to PE, and this was observed for 
both CD56dim and CD56bright NK cells.  
Germain et al. [2007] found that circulating syncytiotrophoblast microparticles stimulated a TH1 
type of cytokine production in peripheral blood mononuclear cells. For instance TNF-α, IFN-γ and 
IL-18 showed to be elevated after 4 hours with circulating syncytiotrophoblast microparticles, 
which is characterized as proinflammatory. Furthermore, an elevated level of circulating 
syncytiotrophoblast microparticles have been related to PE [Germain et al. 2007] and as mentioned 
in the paragraph “Overview of the Predominant Theories Regarding the Cause of Pre-eclampsia” an 
elevated level of debris shedding, which is related to circulating syncytiotrophoblast microparticles, 
is observed [reviewed in Redman & Sargent 2000], so maybe the debris shed from placenta can be 
the reason for the change in of systemic TH1/TH2 balance in PE. 
In general, the TH1/TH2 model might be too simplistic. As described in the paragraph “Introduction 
to the Human Immune System” many additional TH cells have been discovered with different 
cytokine profiles. And with the knowledge from the experiment by Borzychowski et al. [2005] it 
can be questioned whether the main player in controlling the response is the TH cells. Because of 
this it might be better to call it type 1 /type 2 balance instead of TH1/TH2 balance, if it is not the T 
cells that are involved. 
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Tolerance Induction and Pre­eclampsia 
A route for inducing tolerance is via oral exposure to antigens as described in the paragraph 
“Introduction to the human Immune System”. Therefore, Koelman et al. [2000] studied whether 
oral exposure to paternal antigens played a part in developing PE, as inadequate tolerance induction 
might be a leading cause of the syndrome in accordance with the hypothesis that immunological 
factors play a major role in PE. 
Koelman and colleagues [2000] studied the risk of PE in correlation to the practise of oral sex. They 
compared 41 primiparous pre-eclamptic women with 44 primiparous controls. The women were 
asked to fill out a questionnaire and answer whether they had oral sex before the pregnancy and if 
the answer was positive, they were questioned if they swallowed the sperm or not. Out of the pre-
eclamptic women, 18 had oral sex before the pregnancy (44%) compared to 36 in the control group 
(82%). Only 17% of the pre-eclamptic women said that they swallowed the sperm, whereas 48% of 
the control group did. This leads to a hypothesis that oral sex and oral exposure to sperm reduce the 
risk of PE. The thought is that oral exposure to sperm can induce a form of tolerance against 
paternally derived antigens and that this will protect the semi-allogenic fetus, because the maternal 
immune system is modulated to tolerate the foreign antigens. The differences between the oral 
exposure to sperm in pre-eclamptic women and controls in the study by Koelman et al. [2000] 
showed statistically significance, but the number of studied subjects was very small and a larger 
experiment is necessary to confirm the findings.  
Studies have also implied that exposure to seminal fluids during intercourse induces tolerance, as 
Robillard et al. [1995] showed that a long lasting sex life without use of barrier contraception 
lowered the risk of PE, and furthermore, another study showed that the risk of developing PE were 
higher for women who received donor sperm, which supports the hypothesis (see paragraph “Risk 
Factors for the Development of Pre-eclampsia”). It is possible that the semen initiates an immune 
response in the female genital tract. As written in paragraph “Introduction to the Human Immune 
System”, low doses of a foreign antigen is able to induce tolerance, and the ongoing exposure to 
low doses of HLA molecules during intercourses might lead to tolerance of the paternal antigens by 
the immune system of the woman, hereby enhancing a successful pregnancy.  
Saito et al. [2007b] propose that the mechanism of tolerance works via seminal priming of 
regulatory T cells. They believe that the priming has to reach a certain threshold to save the woman 
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from having PE. After a first pregnancy Saito et al. [2007b] suggest that the immune system of the 
mother has developed a specific type of memory T cells that will protect the mother from PE in 
subsequent pregnancies. But if the time between the pregnancies is too long, the number of memory 
T cells might have decreased leading to a higher risk of PE in accordance with the observed 
increase in risk of women with very long intervals between pregnancies [Skjærven et al. 2002] (see 
paragraph “Risk Factors for the Development of Pre-eclampsia”). However these speculations have 
not yet been confirmed or rejected by experiments. 
Koelman et al. [2000] propose that the oral tolerance induction they observed is induced because of 
the soluble classic HLA class I molecules they have detected in seminal plasma. They found both 
soluble HLA-A and HLA-B isoforms in the seminal plasma. The level of these soluble HLA 
molecules in seminal plasma did not show any significant difference when comparing samples from 
men related to pre-eclamptic cases and men fathering normal pregnancies. However, the frequency 
of exposure to sperm might play a part, but this was not examined in the study by Koelman et al. 
[2000]. 
Since trophoblast cells do not express HLA-A and HLA-B, Koelman et al. [2000] suggest that 
tolerance induced to the classic HLA class I molecules can be spread and lead to tolerance against 
other HLA molecules, as for instance HLA-C, E, F and G, which level were not examined in the 
test samples. However, Larsen & Hviid [2009, in preparation] have observed that soluble HLA-G 
is present in seminal plasma and this might explain how exposure to semen is able to reduce the risk 
of PE, perhaps through some of the mechanisms described in the paragraph “HLA-G and its 
Interaction with Immune Cells”. 
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Discussion  
Epidemiological studies suggest that there is an immunological cause of PE, and it is argued that 
tolerance of paternal antigens reduces the risk of PE, wherefore this will be discussed shortly, 
because HLA molecules could play a part in the tolerance induction. Hereafter we will focus 
specifically on first HLA-G and then HLA-C in connection with PE. First, the level of HLA-G in 
PE will be discussed since many studies have suggested a role for HLA-G in PE caused by a change 
in expression level. In relation to this, several HLA-G polymorphisms have been examined in the 
search for a correlation with PE. In this context, there will be a special focus on the +14 bp 
polymorphism, because this polymorphism is well investigated and is coupled to other 
polymorphisms mentioned in association with PE. 
Other studies have focused on the function of HLA-G in relation to immune cells rather than 
studied the level of HLA-G during pregnancy and PE. This research is interesting to discuss in the 
search for hypotheses regarding how HLA-G expressed on trophoblast cells might interact with the 
maternal immune system. Hereafter the focus will be on HLA-C and its interaction with dNK cells, 
since this is the most studied issue in relation to HLA-C and PE. Only one polymorphism of HLA-C 
has been studied in relation to PE, which will also be included. 
Since there are many different discussion themes, a summary of the discussion can be found at the 
end of this paragraph, just before the conclusion. 
Induction of Tolerance 
The epidemiological studies raise some questions regarding risk factors of PE. The increased risk of 
PE in first-time mothers is difficult to explain but yet again leads to considerations of an 
immunological implication. The first pregnancy can possibly prime the maternal immune system so 
it might adapt better to a fetus during a second pregnancy. This priming could involve appropriate 
expression of sHLA-G or other HLA molecules in the circulation. What an appropriate level might 
be has not yet been established but it has been reported that a substantial expression of HLA-G can 
induce a TH2 response while a lower expression will generate a TH1 response which is undesirable 
during pregnancy. In addition, memory T cells could be involved in inducing tolerance via oral sex 
or through sexual intercourse without barrier contraception. However, this priming would be 
transient as the risk of PE is found to be increased to the same level as in first time pregnancies if 
the second pregnancy occurs after ten years. This could be explained by a decrease in the number of 
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memory T cells to protect the fetus after a certain time interval. Another explanation could be that 
priming of the mothers immune system, which might happen during pregnancy, oral sex or sexual 
relationship, should be induced regularly and if this does not happen, the immune system cannot 
deliver the appropriate response to a semi-allogenic fetus – that being expression of HLA molecules 
and/or perhaps a modulation of the TH1/ TH2 response. 
The fact that induction of tolerance could play a part in reducing the risk of PE is supported by 
several findings; a long sexual cohabitation between father and mother without use of barrier 
contraception has been reported to be associated with a reduced risk of PE. This was shown by 
Robillard et al. [1995] studying 1011 women, of whom only 21 had PE or eclampsia. However, a 
larger study on the subject containing more PE women would be preferred to strengthen their 
conclusion. The induction of tolerance to paternal antigens has, as mentioned, been shown in a 
small study of oral sex in association with PE, where oral sex was observed to decrease the risk of 
PE [Koelman et al.2000]. Nevertheless the frequency of oral sex was not taken into account, which 
is a weakness of the study as one time of swallowing paternal antigens in the form of sperm might 
not be enough to induce tolerance. However it is interesting that sHLA-G have been observed in 
seminal plasma. This might lead to immuno-regulation in the woman through the different 
functions of HLA-G. In addition, insemination with donor sperm results in increased risk of 
developing PE versus insemination with sperm of the partner [Smith et al. 1997]. This, again 
indicate that tolerance induction from a partner’s antigens might be important. A change in partner 
has also been reported to increase the risk of PE [Lie et al. 1998]. However, one study [Skjærven et 
al. 2002] found this not to be true. Both studies include more or less the same number of births and 
deal with Norwegian data. Therefore it seems surprising that they do not come to the same 
conclusion, as both studies adjusted for interval between pregnancies. Furthermore, the association 
between a change in partner and hereby lack of tolerance induction is not clear because a change in 
partner does not imply absence of sexual intercourse (and thereby new development of tolerance) 
between the new partner and the women. If a certain time-interval is needed for tolerance to be 
induced, and if a change in partner results in pregnancy immediately after the start of a relationship, 
this might be the cause of the increased risk of PE. Neither [Lie et al. 1998] nor [Skjærven et al. 
2002] states how long the mother and the new partner have been involved before the pregnancy 
occurred, which can be criticized.  
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It could be interesting to look at the “pregnancy interval theory” proposed by Skjærven et al. [2002] 
in other ethnicities to see if it holds true. Induction of tolerance should be investigated further as not 
much is certain about this in relation to PE. Tolerance is not likely to be the sole determinant for 
development of PE and there is evidence for both an immunological and genetic component in PE. 
Nevertheless one cause does not preclude the other and an interaction of the two components might 
decide the occurrence of PE. Specific alleles of one or more genes could affect the mother’s ability 
to retain pregnancy and certain maternal-paternal combination of these alleles could increase the 
risk of PE possibly because of a harmful immunological response. The response might be avoided 
by development of tolerance by the mother through exposure to paternal sperm cells as suggested 
earlier in this paragraph. 
HLA­G Expression Level and Relevance in Pre­eclampsia 
A particular strong HLA-G expression has been observed in the placenta, compared to other HLA 
molecules. In addition, HLA-G displays limited polymorphism compared to classical HLA class I 
genes and class II genes, which further supports that HLA-G would not generate an immune 
response when expressed on the trophoblast cells. Therefore, studies have investigated the 
expression of HLA-G in normal pregnancies and PE women, to elucidate whether a reduction in 
HLA-G expression in pre-eclamptic women could be associated with unsuccessful pregnancies.   
[Colbern et al.1994] reported a reduced HLA-G expression in placentas from PE cases however this 
was not supported by Shobu et al. [2006] that found no difference between HLA-G expression in 
pre-eclamptic placentas and placentas from healthy pregnant women. [Colbern et al.1994] did not 
consider development of necrosis in the pre-eclamptic placentas, which can explain the reduced 
HLA-G expression. However, other studies [Goldman-Wohl et al. 2000; Lim et al. 1997] still found 
reduced HLA-G expression in pre-eclamptic placentas when taking necrosis into account. Thus the 
mentioned results are conflicting, which could imply that other factors or other HLA molecules 
located in the placenta might also be important for a normal pregnancy to occur, and alteration in 
these could result in PE. In this context it is interesting that HLA-DR molecules have been found in 
placentas form pre-eclamptic women, while none was found in healthy pregnant women [reviewed 
in de Luca Brunori et al. 2000]. It could therefore be speculated that one of these factors might be a 
presence of maternal HLA-DR in placenta, through rupture of the placenta, which possibly could 
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lead to a maternal rejection of the fetus. However, generally it is difficult to determine what is the 
leading cause of PE and what is the subsequent consequence of the syndrome.  
Research found no association between PE and the presence of the G*0105N allele in fetuses and 
furthermore, it was shown that fetuses homozygous for the G*0105N allele did not develop PE 
[Aldrich et al. 2000], which argue against HLA-G being important in development of PE. However 
it was shown that even though G*0105N is considered to be a null allele there are still some 
isoforms (G2, G3, G6 and G7), which are unaffected by the truncation and thus are still transcribed. 
In addition the G*0105N allele has been shown to have the capability to protect cells against NK 
cytolysis [Le Discorde et al. 2005] and induce cell surface expression of HLA-E molecules [Sala et 
al. 2004], which might play a part in the immune regulation. Also HLA-G2, HLA-G3, and HLA-G4 
have been shown to inhibit both NK cell- and cytotoxic T lymphocyte cytolysis in vitro [Riteau et 
al. 2001]. On the basis of this, it cannot be ruled out that the expression of HLA-G plays an 
important role for the development of a normal pregnancy. In this context it would be interesting to 
look at the G*0113N allele, which is truncated in exon 2, in comparison to G*0105N, which is 
truncated in exon 4. Because of the earlier truncation in G*0113N, more of the protein function 
might be lost, and therefore a study regarding the function of G*0113N and a case control study of 
this allele in regard to PE would be interesting.   
An Association Between the Different HLA­G Polymorphisms and an 
Increased Risk of Pre­eclampsia 
It is important to mention that the studies investigating the association between PE and 
polymorphisms have different criteria for the diagnosis of PE. Some studies investigate the 
association in certain populations with same ethnic background, thereby making sure that the 
population has the same allele distribution. Some studies include patients with both severe and mild 
PE, while others do not. Furthermore some studies do not differentiate between severe and mild PE. 
Not all studies specify if the subjects included are primi- or multiparas. These differences might 
explain some of the contradicting results in the following paragraph.   
Carreiras et al. [2002] investigated the relation between PE and different HLA-G variants. The 
result showed that maternal inheritance of G*0104 might be considered as a conditioning factor for 
PE. Hylenius et al. [2004] failed to reproduce the results, and this study was much larger than 
Carreiras et al. [2002]. Hylenius et al. [2004] examined a different ethnic group than Carreiras et al. 
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[2002] and differences in allele distribution are likely to exist between these. However, a 
polymorphism must be expected to have the same influence on the development of PE in different 
ethnic groups. The findings of Carreiras et al. [2002] are based on 27 pre-eclamptic cases where 
only six of the women had the G*0104 allele and five out of the six infants, having the allele, 
inherited the allele from the mother. The results showed statistical significance but were only based 
on a few cases and the control group in this study also only included 29 subjects where only one 
woman had the allele. These results might be different if more subjects were included because then 
more women would possess the allele and this would give a more believably result. More studies 
have to confirm the same result obtained by Carreiras et al. [2002] before an association between 
PE and a maternal inheritance of G*0104 can be determined.  
It is not clear how the maternal inheritance of an allele can result in PE, because it does not seem to 
be the allele itself which causes the problem as an equal number of infants with the G*0104 allele 
were found in the pre-eclamptic group and the control group. This means that it is the combination 
of the allele present in both the fetus and the mother which constitutes a risk factor. It could be 
speculated that it is maternal sHLA-G molecules that contributes to the risk. Lack of sHLA-G 
expression together with lack of HLA-G expressed by the trophoblasts could lead to failure in 
suppressing the maternal immune system which then might results in PE. 
 
The 14 bp insertion/deletion and linked polymorphisms 
As described before, the -14 bp polymorphism is a variant only seen in humans [Castro et al. 2000]. 
Not only is it present in humans but it appears to be more frequent than alleles which have the +14 
bp sequence. This is interesting as it could imply an evolutionary advantage since it has undergone 
positive selection. The advantage could be a protection against PE as it has been suggested. This 
suggestion is made on the basis of studies that have reported an excess of the +14 allele amongst 
women with PE and their children. However, there is no consensus on the issue as several other 
studies have failed to find this association.        
The contradicting results cannot be explained offhand, however, Hylenius et al. [2004] who showed 
an association only included women with severe PE. Iversen et al. [2008] also included women 
with milder forms of PE and Tan et al. [2008] does not mention any included PE subjects diagnosed 
with severe PE. The two last-mentioned studies found no association between the +14 bp allele in 
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offspring and development of PE. The varying inclusion criteria and diagnosis of PE in the studies 
could explain the contradicting results as Hylenius et al. [2004] solely included women with severe 
PE. Perhaps there is a greater risk of the milder PE forms being caused by other factors than HLA-G 
polymorphisms in the offspring. Iversen et al. [2008] does not specify how they defined severe PE 
but the conflicting results between this study and Hylenius et al. [2004] could be due to a relatively 
small cohort of subjects used by Iversen et al. [2008] (31 PE and 34 controls) and in particular 
women suffering from severe PE (5 persons). Furthermore the method of obtaining maternal DNA 
was problematic because Iversen et al. [2008] used serum which can be contaminated with fetal 
DNA. 
O’Brien et al. [2001] used placentas from normal and mild PE cases and found, in addition to an 
association between the +14 bp and PE, also reduced HLA-G3 in homozygotic +14 subjects. It 
was, however, a very small study including only 18 placentas (11 normal and 7 PE) and not much 
can be derived from such a small number of samples. The evidence for the +14 bp polymorphism 
being in association with PE is controversial and it is very difficult to compare studies because 
inclusion criteria in the different studies vary.  
Another finding which raises questions about the origin of observed HLA-G down-regulation in PE 
is the fact that the transcript of the +14 bp polymorphism that lacks 92 bp, appears to be more 
stable than the -14 bp transcript. This is not in accordance with the reduced HLA-G found in PE 
cases with the +14 bp polymorphism. But the findings of Yie et al. [2008] provide evidence that, 
the mutation 1745ΔA in the 3’UTR, adjacent to an AUUUA motif which is furthermore linked to 
+14 bp polymorphism, could be one of the mechanisms causing the observed HLA-G down-
regulation in PE. Yie et al. [2008] results showed that the 1745ΔA polymorphism was associated 
with PE and caused lowered mRNA stability. The combination of the +14 bp polymorphism and 
the 1745ΔA polymorphism could explain the reduced HLA-G level observed in PE which could not 
be explained offhand by the +14 bp polymorphism alone, as the mRNA from this allele is more 
stable than the normal transcript. Yie et al. [2008] found that homozygous offspring in regard to the 
1745ΔA polymorphism were strongly associated with severe PE. This could be caused by a 
significantly reduced protein level caused by mRNA instability. This lack of HLA-G expression 
could cause an immune response towards the affected trophoblasts. However, the study by Yie et al. 
[2008] is a small study and it is to be confirmed by other studies before being validated. In addition, 
since the 1745ΔA polymorphism is linked to the +14 bp sequence, it is possible that it actually is 
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the +14 bp sequence which is responsible for the association with PE. Nevertheless in the case of 
the 1745ΔA allele there is a functional explanation for the association because the mRNA was 
reported to be unstable. This was not the case when two alleles with the +14 polymorphism, 
G*010103 and G*010102, were investigated in the same context. It is possible that it is not stability 
but transcription of HLA-G which is suppressed in individuals expressing the +14 bp polymorphism 
though this probably would have been detected in the study by Rousseau et al. [2003] which 
measured total amount of HLA-G mRNA and found a higher level of the smaller transcript (-92 bp) 
than the other version (+92 bp). It is possible but unlikely that a longer period before blocking of 
mRNA transcription would have revealed a difference in transcription level, though Rousseau et al. 
[2003] do not specify how long time transcription were allowed before blocking it. Therefore, the 
lowered level of HLA-G found in PE have not been proven to be directly linked to the +14 bp 
sequence even though studies have seen reduced levels of both soluble and membrane bound HLA-
G in PE cases and of membrane bound HLA-G in tissues homozygous for the +14 bp allele. It 
would be preferable to make a study where all the polymorphisms, which have been associated with 
PE were investigated in relation to both mRNA and protein expression.  
Moreau et al. [2008] found that the G*0106 allele was observed significantly more often in PE 
offspring compared to controls. This was supported by Hylenius et al. [2004] and Tan et al. [2004]. 
Interestingly, the polymorphism in the G*0106 allele is located in the α3-domain, which could 
interfere with the ILT-2 binding site and thereby the product of this allele might not be able to 
inhibit the NK cells.   
Tan et al. [2004] found that especially paternal transmission was associated with PE. Furthermore, 
it has been observed that multipara Malay women have an increased risk of PE when the fetus 
inherited the G*0106 allele from the father. Tan et al. [2004] suggest that this case might cause PE 
because of maternal exposure to a foreign variant of HLA-G. The fact that the association was only 
seen in multipara pregnancies could be because the response is a gradual immune response rather 
than an instant. This is not in correspondence with results obtained from epidemiological studies 
showing higher risk for PE in primiparas [Skjærven et al. 2002]. Furthermore, according to 
Hylenius et al. [2004] the mechanism of an immune response towards a foreign variant of HLA-G 
does not take place, as they investigated HLA-G incompatibility and found no evidence supporting 
the hypothesis, that foreign HLA-G variants in offspring contributes to risk of PE. These studies 
indicates that there might be an association between the G*0106 allele and PE but the studies only 
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included a small group of samples and therefore the result needs to be reproduced in larger studies. 
Furthermore, the linking of this allele with the +14 bp polymorphism makes it difficult to 
distinguish whether it really is the G*0106 allele which is responsible for the association with PE or 
it is the linking with the +14 bp sequence.       
Many HLA-G alleles have been found in different studies but none of the results are conclusive in 
relation to an association with PE. It would have been relevant to present a meta-analysis of the 
different HLA-G polymorphism to come to a more final conclusion, but the methods used in the 
studies have shown to be too different to do a statistical comparison. 
HLA­G and the Immune System 
Different theories have been proposed on the effect of HLA-G in connection with the immune 
system. In general, studies investigate the influence of different HLA-G isoforms on immune cells, 
such as the effect on NK cells, T cells, and DCs. In these studies HLA-G is found to have an 
inhibiting effect on T cells, NK cells and DCs. Furthermore an up-regulation of inhibitory receptors 
are seen in antigen presenting cells, T cells and NK cells as a result of HLA-G stimuli. 
The results of the different studies give the impression that HLA-G works through many different 
pathways, and that the effect of the antigens cannot be explained by one single mechanism. 
Therefore we find it very likely that HLA-G interacts with both NK cells, T cells and DCs, and that 
this interaction happens through different receptors on the immune cells. Because NK cells, T cells 
and DCs are found to be present in the placenta, these are interesting immune cells in the 
investigation of HLA-G’s role in pregnancy and in development of PE. 
It is worth noticing that the above-mentioned studies are not consistent in their obtainment of the 
immune cells used in their experiments. In a majority of the studies presented here, NK cells are 
derived from peripheral blood, with one exception where dNK cells are used. In regard to T cells 
and DCs, none of the presented studies investigated cells derived from the decidua. Cells derived 
from peripheral blood might not give a precise view of HLA-G’s function during pregnancy, 
because blood NK cells have a different receptor expression pattern compared to dNK cells. This 
and possibly other factors, separate peripheral derived blood NK cells from dNK cell, thus they 
might have a slightly different function. The same pattern is likely to be seen for T cells and DCs. 
For instance in regard to HLA-E it was found that different subpopulations of γδ T cells were 
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scattered differently, that the pattern changed in pregnancy, and that HLA-E only recognized one of 
the subpopulations. 
However, as described previously, studies have shown that sHLA-G is normally found in higher 
levels in the blood during normal pregnancy compared to nonpregnant women, indicating that 
sHLA-G in the blood might also play a part in pregnancy. Furthermore samples homozygotic for 
the +14 bp allele, which is thought to be associated with PE, is linked with an undetectable level of 
sHLA-G in the blood [Chen et al. 2008; Hviid et al. 2004]. Therefore a possible lower level of 
sHLA-G in the blood in PE cases might be the reason for a change in the modulation of a systemic 
type of immune response observed in PE. 
A majority of the studies investigates peripheral blood immune cells in connection with HLA-G, 
and have not had PE as a focus. Because these studies have a different focus it might be difficult to 
draw conclusions regarding immune cells in connection with PE. However, Rouas-Freiss and co-
workers [1997b] proved that dNK cells were indeed inhibited by the presence of HLA-G on 
trophoblast cells, hereby creating a potential connection to PE. A point of criticism of the study is 
that they only included six semi-allogenic-, and 20 allogenic combinations of trophoblasts and NK 
cells. More research regarding decidua derived NK cells, T cells, and DCs in connection with HLA-
G will be needed. 
None of the above-mentioned studies contradicts each other neither do they reach an agreement. 
Though, Bahri et al. [2006] did not find that HLA-G induced T cell apoptosis, as observed by 
Fournel et al. [2000]. This might be explained by the fact that they only measured apoptosis in the 
early events of HLA-G-related inhibition of T cell proliferation. Because of this, a later induction of 
T cell apoptosis cannot be excluded, and since apoptosis have been detected by other studies 
[Contini et al. 2003; Zavazava & Kronke 1996] it seems likely that HLA-G have this effect on T 
cells [Bahri et al. 2006]. 
Most research regarding HLA-G and the interaction with maternal immune cells have concentrated 
on HLA-G1 and HLA-G5 in connection with PE, but it is reported that also HLA-G2, HLA-G3, and 
HLA-G4 can inhibit both NK cell and cytotoxic T lymphocyte cytolysis in vitro [Riteau et al. 
2001]. The inhibition of NK lysis was shown not to occur through HLA-E as shown by other 
studies [Lee et al. 1998b]. The inhibition might be caused by interaction with KIR2DL4 or ILT-2 
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which have been shown to bind directly to HLA-G, see paragraph “The Function of NK Cells in 
Relation to HLA Molecules”. 
The findings that other HLA-G isoforms than HLA-G1 and HLA-G5 can inhibit NK cells and 
cytotoxic T lymphocytes is, as mentioned of interest in situations where HLA-G1 expression is 
altered, such as seen with mutations which do not affect all isoforms. In these cases it is likely that 
HLA-G2, -G3 and -G4 would be of particular importance maintaining a normal pregnancy. This is 
also supported by the fact that fetuses homozygous for the G*0105N does not result in development 
of PE. Therefore it may be speculated that the full length isoforms, HLA-G1 and HLA-G5, is not 
essential for a normal pregnancy, even though both have been shown to inhibit the NK and T cell 
lysis. Apart from this it could also mean that HLA-G is not the sole determinant for development of 
PE, and other factors might play a part. 
Furthermore functional overlap of the non-classical HLA molecules, such as HLA-E and –F, and 
the classical HLA-C might rescue an individual with a mutation in either of these genes from 
experiencing PE. However several mutations in the different loci might raise susceptibility for the 
disorder. That is, numerous, positive and negative combinations of loci could exist in regard to PE. 
Findings in regard to HLA-G and the immune system might be a key factor in understanding how 
certain HLA-G variants can protect the fetus against a maternal immune response and how some 
fail to do so. Furthermore, it is likely that future research will find even more pathways or 
mechanisms through which HLA molecules interact with maternal immune cells to secure a 
successful pregnancy. It is also possible that different individuals for instance secrete different 
amounts of cytokines, and have a different HLA expression pattern etc. because of polymorphisms, 
and hereby a normal pregnancy might depend on both cytokine- and polymorphism profiles. This 
will make research more difficult because it will be harder to grasp these complicated factors and 
compare individuals. 
It can be argued that dNK cells are of special importance compared to T cells and CDs when 
examining the relation to HLA-G and PE, since there are many more dNK cells in the placenta than 
T cells [reviewed in Tabiasco et al. 2006]. Because of this, dNK cells in regard to the risk of 
developing PE will be discussed further in the next paragraph. 
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HLA­G and its Impact on NK cells and Type 1 and Type 2 Response 
In regards to HLA-G, Hanna et al. [2006] showed that binding of HLA-G to ILT2 on dNK cells 
inhibited the secretion of VEGF, PLGF, IL-8 and IP-10 by dNK cells, probably leading to an 
inhibited trophoblast invasion, because IL-8 and IP-10 were shown to simulate trophoblast 
invasion. From these results it could be hypothesised that HLA-G inhibits the dNK cells and hereby 
leads to development of PE. But this does not correlate with the observations that there is often seen 
a reduced level of HLA-G in PE, neither does it correlate with HLA-G’s inhibitory effect on the 
cytotoxic NK cell function. It could be speculated that different isoforms of HLA-G play a part in 
this mechanism, presuming that these isoforms could react with NK cells in different ways. 
Therefore a relative concentration of different isoforms might also be important. For instance it is 
possible that sHLA-G molecules might have another effect than membrane bound molecules. 
Furthermore, it could be suggested that the gene expression of NK receptors play a part in relation 
to the interaction with HLA-G, as it has been shown for HLA-C and KIR haplotypes. We could 
hypothezise that dNK cells might have more activating receptors than inhibitory for HLA-G, but if 
the inhibitory receptors have a higher affinity for HLA-G, it would demand a large concentration of 
HLA-G to bind enough activating receptors, hereby giving an overall activating signal to the dNK 
cell, leading to secretion of cytokines. If this is the case, the lower level of HLA-G in PE fits with 
this hypothesis, because this would lead to inhibition of dNK cells, eventually followed by 
incomplete trophoblast invasion, however this might be controversial. From the study by Hanna et 
al. [2006] it can be deduced that HLA-G might not only function as an inhibitor of the lytic activity 
of NK cells as believed until recently, because inhibition of dNK cells by HLA-G leads to inhibition 
of secretion of important growth factors by the NK cell.  
A range of other studies still support the original idea that HLA-G is important in the inhibition of 
NK cells as described in the previous paragraph. The findings all together support a role for HLA-G 
in the regulation of NK cells, although only one study has examined dNK cells in correlation with 
its lytic function. It can be suggested that HLA-G act as an inhibitor of dNK cells during pregnancy 
and thereby inhibits the lysis of trophoblast cells. The mechanism involved in development of PE is 
therefore proposed to be a lower concentration of HLA-G leading to incomplete inhibition of dNK 
cells and hereby lysis of trophoblast cells. Perhaps this could, at the same time, reduce a HLA-G 
induced activation of cytokines secretion by dNK cells, which may be unfavourable. 
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It has been shown that NK cells are the lymphocytes responsible for the observed change in type 1/ 
type 2 balance of cytokines in PE [Borzychowski et al. 2005], and furthermore HLA-G has been 
shown to have an influence on the general systemic cytokine balance [Kapasi et al. 2000]. On the 
basis of this and studies which propose an interaction between HLA-G and NK cells, it can be 
suggested that HLA-G might have an impact on the cytokine balance via interaction with NK cells. 
However, HLA-G is mainly present on the trophoblast cells in placenta, and the observation of 
change in NK cell cytokine profiles have been made from examinations of NK cells derived from 
peripheral blood lymphocytes. Therefore the suggestion of a connection between the HLA-G on 
trophoblast cells and the overall systemic change in the type1/type2 balance might be 
unsubstantiated. However as mentioned sHLA-G in the blood might play a part in the systemic type 
of immune response observed in PE. Type 1 cytokines have also been observed to inhibit 
trophoblast invasion by induction of apoptosis, so maybe some relevant interactions between HLA-
G and the systemic immune response do take place during placentation. 
It would be interesting if all studies on interaction between HLA-G and immune cells had examined 
the results of different levels/concentrations of HLA-G, because Kapasi et al. [2000] showed that 
this was important for the inhibition of cytotoxic T lymphocytes and the mediated change in 
type1/type2 balance. A relatively high concentration of HLA-G inhibited the cytotoxic T 
lymphocytes and changed the cytokine profile towards a type 2, whereas lower concentrations 
enhanced the activity of cytotoxic T lymphocytes and changed the overall cytokine profile toward 
type 1. These results are consistent with the lower concentration of HLA-G in PE, because then 
HLA-G might be in such a low concentration that the inhibition of the cytotoxic T lymphocytes and 
the change in overall cytokine profile towards type 2 do not take place in the same extent as in 
uncomplicated pregnancies or the low concentration could even result in activation of the cytotoxic 
T lymphocytes. 
As noted before, the model of the type1/type2 cytokine balance may be too simplistic, and it might 
not be possible to come to a conclusion by examining only single cytokine levels. Instead an overall 
cytokine profile and how the individual cytokines might interact with each other through different 
pathways would be interesting to map in relation to PE. In addition Germain et al. [2007] showed 
that circulating syncytiotrophoblast microparticles induced a change in cytokine profile towards a 
type 1 and a systemic inflammatory response, so maybe it is more likely that circulating 
syncytiotrophoblast microparticles, rather than HLA-G, change the overall cytokine profile, since 
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these are in direct contact with the peripheral maternal immune system. It could also be 
hypothezised that circulating syncytiotrophoblast microparticles and HLA-G both have an influence 
of the type 1/ type 2 response, but that this influence results in an opposite response. 
HLA­C and its Interaction with NK Cells 
Hiby et al. [2004] concludes that if a woman has the KIR A haplotype, and the fetus has a HLA-C2 
gene, the risk of PE increases markedly. However, some develop PE without this combination of 
genes between mother and fetus, so the polymorphisms of KIR and HLA-C cannot explain all 
incidences of the syndrome, even though the suggested mechanism by which the combination leads 
to increased risk seems reasonable. The KIR A haplotype leads to dNK cells mainly having 
inhibiting receptors and therefore Hiby et al. [2004] have suggested that they are more easily 
inhibited than activated compared to people with the KIR B haplotype. Furthermore, HLA-C2 is 
proposed to have a stronger binding to the inhibitory receptor compared to HLA-C1. Overall, the 
combination of KIR A and HLA-C2 will then lead to stronger inhibition of the dNK cells, which 
could be suggested to be unfavourable during pregnancy, in regard of cytokine secretion, if taking 
the research by Hanna et al. [2006] into consideration. The interaction of HLA-C and NK cells were 
shown to have nothing to do with NK cells recognizing and reacting against non-self HLA 
molecules as it also was shown for HLA-G by Hylenius et al. [2004]. The interaction mechanism 
between NK cells and HLA-C must therefore be different than believed by classical immunology, 
which will be discussed later in this paragraph. 
Saito et al. [2006] have conducted another study that does not support the hypothesis by Hiby et al. 
[2004]. They examined the incidence of pre-eclamptic cases in couples of Japanese women, who 
are believed to have a relatively high frequency of KIR A, and Caucasian men, who are believed to 
have a relatively higher frequency of HLA-C2 compared to Japanese men. Saito et al. [2006] found 
that the frequency of PE among couples of Japanese women and Caucasian men were only 1.54% 
compared to 2.67% in controls. It is problematic that the study did not check the genotypes of the 
mothers and fetuses to examine whether a higher incidence of KIR A and HLA-C2, respectively, 
existed. If the genotypes were studied, the basis for a conclusion contradicting the one put forward 
by Hiby et al. [2004] would be better supported. And obviously a larger number of pre-eclamptic 
study subjects would validate the results to a greater extend, since Hiby et al. [2004] examined 200 
women with PE and Saito et al. [2006] could only have studied five subjects (1.54% of 324 
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couples) with PE. Furthermore, Saito et al. [2006] have not noted the nationality of the control 
group, but they assumed that 98% consist of Japanese couples. This should have been verified, even 
though the assumption seems reasonable since the data originates from a Japan Society for 
Obstetrics and Gynaecology database.  
One point of criticism regarding the study made by Hiby et al. [2004] is that they do not present 
many reflections on how the study subjects have been selected, including the ones in the control 
group. They simply write that the control group was matched with the study group. In contrast, 
Saito et al. [2006] have only selected singleton pregnancies and they present how many of the 
women are primipara etc. It would furthermore have been interesting if Hiby et al. [2004] had 
studied the expression level of the different KIR especially in dNK cells, because this is important 
in relation to the difference between NK cells, dNK cells, and their function.  
The study by Hanna et al. [2006] supports the idea of a complex interaction between dNK cells and 
HLA-C, although they focus on the overall interactions between trophoblasts and dNK cells. They 
showed that dNK cells secrete IL-8 and IP-10 that stimulate trophoblast invasion. Trophoblast cells 
probably also regulate dNK cell activity through binding to dNK cells via HLA-C and HLA-G. 
Binding of HLA-Cw4 and HLA-Cw6 to inhibitory receptors on dNK cells inhibit the secretion of 
VEGF, PLGF, IL-8 and IP-10 of dNK cells, whereas binding of HLA-Cw4 but not HLA-Cw6 to 
activating receptors on dNK cells stimulate the secretion of growth factors by dNK cells. Since 
these growth factors have been shown to stimulate trophoblast invasion and remodelling of 
maternal spiral arteries, Hanna et al. [2006] support the hypothesis that HLA-C plays an important 
regulatory role in regard to the dNK cells. HLA-Cw4 and –Cw6 both belong to the HLA-C2 group, 
and therefore Hanna et al. [2006] have not studied the difference between the two HLA-C groups 
like Hiby et al. [2004] have done. However the results can be used to criticise Hiby et al. [2004] for 
creating a too simplistic model by dividing HLA-C into two groups, since Hanna et al. [2006] found 
that the effect of two different HLA-C2 molecules can be quite different, which were shown in 
regard to the activating receptor examined. 
Another study by Hanna et al. [2003] proposes that trophoblast cells secrete chemokines and attract 
specifically dNK cells. This interaction followed by cytokine secretion of dNK cells that have been 
stimulated with HLA class I molecules might lead to trophoblast invasion into the uterine tissue, 
and hereby gives a successful pregnancy. From the above-mentioned studies it can be suggested 
that the dNK cells and HLA molecules interact with each other continuously. 
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In contrast to HLA-G the studies about HLA-C suggest that the main function of HLA-C is to 
activate NK cells. It could be suggested that HLA-G inhibit NK cell lysis and HLA-C activate the 
cytokine secretion of NK cells to promote trophoblast invasion. It could also be speculated that both 
HLA-G and HLA-C have inhibitory as well as activating functions that might be regulated via other 
factors, but further research is needed to clarify this. 
The Relation of HLA­E and HLA Molecules in Regard to NK Cells 
Like HLA-G and HLA-C, HLA-E is also shown to play a part on NK cell cytotoxicity, which might 
contribute to the regulation of the immune system during pregnancy. However the interaction of 
HLA-E on NK cells, have only been investigated on NK cells derived from peripheral blood and 
therefore it cannot be excluded that HLA-E might have a different effect on dNK cells. However it 
has been shown that receptors for HLA-E are up-regulated on dNK cells, indicating that HLA-E 
does play an important role for dNK cells. Since HLA-E expression is scattered throughout the 
body, it could be speculated that HLA-E also can contribute to a systemic regulation of the immune 
system through peripheral blood NK cells. Furthermore it was also shown that HLA-E suppresses 
cytotoxicity of T cells which might also modulate the immune response. The expression pattern of 
HLA-E and HLA-F in the placenta resembles each other, which might suggest that these two 
molecules cooperate or in some way have an impact on one another. HLA-E could possible 
influence the up regulation of HLA-F because HLA-F is not detected on the cell surface during the 
first trimester, but increases in expression thereafter, while HLA-E expression is detected on the cell 
surface and increases from the start of pregnancy. The fact that both HLA-E and –F expression 
increases during pregnancy, suggests an increased importance during pregnancy. 
From above-mentioned it can be deduced that HLA-G, HLA-C and HLA-E probably play a part in 
regulation of dNK cells during pregnancy, also since dNK cells have a higher expression level of 
receptors for these molecules compared to peripheral blood derived NK cells. HLA-G, HLA-C and 
HLA-E have all been thought to have an impact on dNK cell lysis. However, a study by King et al. 
[2000c] showed that trophoblast cells were resistant to lysis of dNK cells even though the HLA 
molecules or the corresponding dNK receptors were inhibited because of binding of antibodies. If 
so, this leads to doubt regarding the thesis that the HLA class I molecules play a prominent role in 
normal pregnancy via inhibition of dNK cells. As proposed, the predominant role of the HLA class 
I molecules could be to activate the dNK cells and mediate important secretion of growth factors 
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that stimulate trophoblast invasion and remodelling of maternal spiral arteries. This is supported by 
the finding that KIR2DL4 bound to HLA-G leads to secretion of pro-angiogenic factors by NK cells 
[Rajagopalan et al. 2006] and the study made by Hanna et al. [2006], that showed close stimulating 
activities between dNK cells and trophoblasts, which is influenced by HLA molecules. 
It could have been relevant if more studies had measured the variation of the level of different 
factors such as HLA molecules and immune cells during normal pregnancy compared to pre-
eclamptic pregnancies, because this could be used to propose when important interactions might 
take place and which factors that are present simultaneously leading to possible interactions of these 
factors. Furthermore such time related expression measurements could indicate which factors might 
play a part in the etiology of the syndrome. 
Summary of the Discussion 
There is evidence for both an immunological and genetic component in PE. Nevertheless one cause 
does not preclude the other and an interaction of many mechanisms could decide the occurrence of 
PE. Specific alleles of one or more genes could affect the mother’s ability to retain pregnancy and 
certain maternal-paternal combination of these alleles could increase the risk of PE possibly 
because of a harmful immunological response. Furthermore, it is found that immunological 
tolerance might play a part in PE shown by epidemiological studies. The mechanism behind 
tolerance induction is however not clear. Some have suggested that sHLA molecules from the father 
might induce tolerance towards the fetus, perhaps through a special kind of memory T cells. 
Induction of tolerance should be investigated further as not much is certain about this in relation to 
PE, but it is not likely to be the sole determinant for development. 
A main finding regarding HLA-G and PE has been that down-regulation of HLA-G is observed in 
pre-eclamptic patient. This has lead to the suggestion that HLA-G play a prominent part in a 
successful pregnancy and is a cause of PE if not expressed at a sufficient level. Furthermore, several 
polymorphisms have been associated with PE but none have been fully validated as a cause of PE. 
However the +14 bp polymorphism has been well investigated and appears to contribute to a risk of 
developing PE when present in offspring. Furthermore, two other polymorphisms, G*0106 and 
1745ΔA, which have been associated with PE when found in offspring, are actually linked to the 14 
bp insertion. The lowered level of HLA-G found in PE does not seem to be directly linked to the 
+14 bp sequence because the stability of the transcript actually has shown to be higher than the 
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normal transcript even though studies have seen reduced levels of both soluble and membrane 
bound HLA-G in pre-eclamptic cases. Therefore the origin of this down-regulation is still unknown, 
however it could be hypothesized that the +14 bp-linked polymorphism 1745ΔA, which has shown 
to decrease the stability of the transcript, is responsible for the down-regulation of HLA-G. The 
contracting results of the research regarding HLA-G polymorphisms could be due to other factors, 
such as genetic background, masking the connection between a polymorphism and PE. Furthermore 
one polymorphism may not influence all HLA-G isoforms and thereby do not lead to overall lack of 
HLA-G resulting in PE. 
In addition to investigating polymorphism of HLA-G, its function has been examined in relation to 
modulation of the immune system. From the different studies made it has been found that HLA-G 
inhibited the cytotoxic function of DCs, NK cells, and T cells. Because these cells are shown to be 
inhibited by HLA-G, and because trophoblast cells express HLA-G during a normal pregnancy this 
might be the reason why maternal immune cells do not cause harm to the fetus. Furthermore, HLA-
G is related to the change from type 1 to type 2 response during normal pregnancy, and therefore 
decreased HLA-G might play a part in the increased type 1 response observed in PE.  
HLA-C’s supposed implication in PE, via interaction with dNK cells, is underlined both by genetic- 
and functional studies. And the idea that the main function of HLA class I molecules on trophoblast 
cells is to protect against NK cell-mediated lysis is contradicted by research suggesting that HLA-C 
probably have an important activating impact on dNK cells, and might be an inducer of dNK cell 
secreted cytokines that promote the invasion of trophoblast cells during implantation. But the 
interaction between HLA-C and NK cells is however quite complex, since many different dNK KIR 
receptors might interact with various HLA-C molecules in a different manner. 
HLA-G, HLA-C, HLA-E and possible other HLA molecules might be involved in a complex 
interaction with dNK cells where the aim is to inhibit dNK cell-mediated lysis as well as activate 
dNK cells to secrete specific favorable cytokines. However, a study shows that other factors than 
HLA class I molecules possibly protect the trophoblast cells against lysis from dNK cells – factors 
that remains to be examined.  
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Conclusion 
Present bachelor project found that the development of PE most likely cannot be explained by a 
single mechanism. Rather it seems that different factors play a part in development of the 
syndrome, such as genetic factors as well as immunological disturbances.  
On the basis of studies examined in this project it seems very likely that the immune system is a 
central factor in the etiology of PE because of interaction with HLA molecules presented on 
trophoblast cells. Regarding HLA-G it has not yet been proven that any specific polymorphism is 
directly associated with PE and the observed down-regulation of HLA-G in PE cases. However, it is 
quite substantiated that the +14 bp polymorphism of HLA-G increases the risk of PE. Furthermore 
the polymorphism G*0106 that is linked to this +14 bp allele has been associated with PE. 
However it is well established that HLA-G molecules can modulate and suppress an immune 
response. This is among other things done through inhibition and apoptosis of cytotoxic NK - and T 
cells.  
HLA-C has also been given some attention as a modulator of especially dNK cells during 
pregnancy, and it is believed that HLA-C is an important activator of dNK cell secretion of 
angionenic factors that mediate the placentation. One group of HLA-C polymophisms have been 
observed to increase the risk of PE, however further research is needed to confirm this. Whether the 
overall interaction of HLA-C and HLA-G with dNK cells is mainly inhibitory, activating or both is 
however debatable. 
From this we can conclude that HLA-G and HLA-C indeed are important factors in regards to a 
successful pregnancy, but further studies are needed to come to a final conclusion about the 
mechanisms behind the observed effects. 
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